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CHAPTER 1: THE STUDY PROBLEM
Introduction
In 1993, the National Adult Literacy Survey reported that more than 40 million
Americans were functionally illiterate, meaning that they could not perform the basic reading
tasks necessary to function fully in society (Kirsch, Jungeblut, Jenkins, & Kolstad 1993).
Although this survey did not include health-related items, these findings suggested that many
Americans—approximately 43%—were unable to read and comprehend essential information
they would likely encounter when seeking health care (Baker et al., 2002).
The 2003 National Adult Literacy Survey indicated that literacy rates in the United States
remained much the same (Kutner, Greenberg, & Baer, 2006). Nearly 90 million adults—almost
half of all adults in the country—lack the literacy skills needed to effectively function in the
present U.S. health system (Nielsen-Bohlman, Panzer, & Kindig, 2004).
In its report entitled Health Literacy: A Prescription to End Confusion, the Institute of
Medicine (Nielsen-Bohlman, et al., 2004) adopted Ratzan and Parkers' (2000) definition of
health literacy as being "the degree to which individuals have the capacity to obtain, process,
and understand basic health information and services needed to make appropriate health care
decisions" (p. 2). In discussing health literacy, the Institute of Medicine emphasized that little
attention is given to whether patients are able to comprehend their condition and treatment,
to make the best decision for their care, and to take the correct medication in the right dose
and at the right time.

Increasingly, the healthcare system in the U.S. imposes complex

demands on adults whereby they are asked to assume new roles in seeking out health
information, understanding rights and responsibilities, and making healthcare decisions for
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themselves and others. Underpinning these demands are assumptions about patients' abilities
and skills (Nielsen-Bohlman, et al., 2004).
Today, many patients are living with chronic conditions that require ongoing proper use
of medications. In fact, more than one in four Americans have multiple (two or more)
concurrent chronic conditions, including asthma, diabetes mellitus, heart disease and
hypertension (Anderson, 2010). To properly manage their chronic conditions, patients need to
know why they need to take their medications, how their medications work and how to
properly use or administer their medications. Studies have shown that patients with limited
literacy have a poorer understanding of prescription medication names, indications for use, and
instructions (Davis, Wolf, Bass, Tilson, et al., 2006; Kalichman, Ramachandran, & Catz, 1999;
Wolf et al., 2005). Limited literacy also been associated with drug therapy problems (e.g.
duplicate medications, adverse effects) and poor adherence by the patient to a particular drug
therapy (Knapp-Dlugosz, 2008).
At the core of the pharmacy profession is the improvement of health outcomes through
the proper use of medications (Brown, 2006). Pharmacists remain among the most accessible
healthcare providers and can be one of the first healthcare providers to recognize that a patient
has lower literacy (Youmans & Schillinger, 2003). As such, knowing the health literacy level of
patients and the association of lower levels of literacy to health outcomes have become
increasingly important to pharmacists. To adequately prepare future pharmacists, colleges of
pharmacy should include training with regard to patient-centered approaches to health care,
which include the relationships between literacy and health (Youmans & Schillinger, 2003).
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Problem Statement
This study was undertaken as a step in furthering understanding the relationships
between health literacy and specific variables in a population of persons taking medication for
the chronic diseases of asthma, cardiovascular disease/hypertension, depression/anxiety and
diabetes mellitus so that educational materials may be developed for pharmacy education.
In particular, this study was guided by the research question: Do the subject
characteristics health literacy, gender, race, age, and levels of education influence clinical
outcomes of patients with asthma, diabetes mellitus, cardiovascular disease/hypertension, and
depression/anxiety?
Purpose of the Study
The purpose of this study was to examine the extent to which health literacy is
associated with different demographic factors (e.g. gender, race, educational level) and the
extent to which health literacy is associated with clinical outcomes for patients with asthma,
diabetes mellitus, cardiovascular disease/hypertension, and depression/anxiety in a welldefined, self-insured university population.
The primary aim of this study was to test the hypothesis that limited health literacy,
alone or in combination with other factors is associated with certain clinical outcomes of
patients

with

asthma,

diabetes

mellitus,

cardiovascular

disease/hypertension,

and

depression/anxiety. The findings of this study will be used in the development of educational
materials for pharmacy education.
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Aims and Hypotheses
As described more fully in Chapter 3, the research question was explored using the
following aims and hypotheses:
1. To evaluate the association of health literacy with the following demographic
factors: gender, race, age, and level of education.
H1a: Limited health literacy is associated with higher age and lower levels of
education.
H1b: Limited health literacy is not associated with gender or race.
2. To evaluate the association of health literacy with clinical outcomes of patients with
asthma,
diabetes
mellitus,
cardiovascular
disease/hypertension,
and
depression/anxiety.
H2a: Limited health literacy is associated with clinical outcomes of asthma, diabetes
mellitus, cardiovascular disease/hypertension, and depression/anxiety.
H2b: Limited health literacy is associated with higher body mass index (BMI), higher
blood pressure, higher fasting blood glucose levels, and dyslipidemia.
H2c: Limited health literacy is associated with lower medication adherence.
H2d: Limited health literacy is associated with the need for patient education.
H2e: Limited health literacy is associated with sub-optimal medication regimens.
3. To construct a logistical regression model to determine independent predictors of
health literacy from among the variables considered in research questions 1 and 2,
above.
H3: Each of the following will independently predict health literacy: gender, race,
age, level of education, health outcomes of asthma, diabetes mellitus,
cardiovascular disease, and depression/anxiety, lower medication adherence,
increased need for patient education, and sub-optimal medication regimens.
Data Sources
Relationships between the study variables: health literacy, and health outcomes of
patients with asthma, diabetes mellitus, cardiovascular disease and depression, as well as
potential co-variates of age, gender, race, and education level, will be tested using data
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previously collected as a part of a university heath wellness Medication Therapy Management
program.
Definition of Terms
To ensure consistency in the implementation and analysis of the study, key terms and
study variables were defined as follows:
Adherence is the extent to which a person's behavior (in terms of taking
medications, following diets, or executing lifestyle changes) coincides with medical
or health advice (Meichenbaum & Turk, 1987). For this study, medication adherence
was measured by patient interviews and the use of the Modified Morisky Scale
(Morisky, Green, & Levine, 1986).
Asthma is an inflammatory lung disease (Poureslami et al., 2007).

Asthma is

considered a common chronic disorder of the airways which is characterized by,
among other things, recurring airflow obstruction (National Heart, 2007). For
purposes of this study, asthma was determined by participants' self-report of being
diagnosed with asthma.

The level of asthma control was measured by the

administration of the Asthma Control Test (QualityMetric Incorporated, 2002).
Body Mass Index (BMI) is a ratio used to describe patient's weight based on patient's
height. It is calculated by dividing a patient's weight by the patient's body surface
area (height in meters squared). A BMI of 25.0-29.9 is considered overweight and a
BMI of 30.0 or above suggests obesity and risk factor for diabetes mellitus and
cardiovascular disease.
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Cardiovascular disease affects the heart and blood vessels. Cardiovascular disease
includes hypertension and is associated with dyslipidemia.

Control of

cardiovascular disease was measured by measuring participants' blood pressure,
BMI, and blood glucose levels.
Chronic illnesses (or chronic diseases) are conditions that last a year or more and
require ongoing medical attention and/or limit activities of daily living (Warshaw,
2006).
Depression is a mental state characterized by a pessimistic sense of inadequacy and
a despondent lack of activity. Depression/ anxiety is often associated with chronic
diseases including asthma, diabetes and cardiovascular disease. For purposes of this
study, depression/anxiety was determined by participants' self-report of being
diagnosed with depression or anxiety. The level of a patient's depression was
measured by the Zung Self-Rating Depression Scale (Zung, 1965).
Dyslipidemia is a condition marked by abnormal concentrations of lipids or
lipoproteins in the blood. For purposes of this study, dyslipidemia was determined
by participants' self-report of being diagnosed with dyslipidemia. The level of a
patient's dyslipidemia was measured by the administration of a blood test
measuring, in milligrams per deciliter (mg/dl): triglycerides, total cholesterol (TC),
high density lipoprotein (HDL), and low density lipoprotein (LDL) cholesterol.
Dyslipidemia is associated with diabetes mellitus and can lead to cardiovascular
disease.
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Diabetes mellitus is a polygenic disease characterized by abnormally high glucose
levels in the blood. For purposes of this study, diabetes mellitus was determined by
participants' self-report of being diagnosed with type 1 or type 2 diabetes and/or the
administration of a blood glucose test after the patient fasts for at least eight hours
(a fasting blood glucose test). There are three levels of blood glucose: normal, prediabetic and diabetic. Patients with diabetes mellitus often also have cardiovascular
diseases.
Functional health literacy is a measure of a person's ability to perform basic reading
and numeric tasks in the healthcare context, such as reading medication labels and
insurance forms and performing mathematical tasks associated with taking
medications (Ad Hoc Committee on Health Literacy for the Council on Scientific
Affairs, 1999).
Health literacy is the degree to which individuals have the capacity to obtain,
process and understand basic health information and services needed to make
appropriate health decisions (Ratzan & Parker, 2000). For purposes of this study,
health literacy was determined by the participants' score on The Newest Vital Sign
(Weiss et al., 2005) and will be categorized as having adequate health literacy or
limited health literacy.
Health outcomes are changes in a patient's health status resulting from healthcare
service. These include mortality (death), morbidity (increased or additional illness),
functional status, and quality of life (Donabedian, 1978). Health outcomes also
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include relief of symptoms, adverse drug interaction, medication adherence and the
need for patient education (Mullins, Baldwin, & Perfetto, 1996).
Hypertension is high blood pressure measured in systolic over diastolic blood
pressure. For purposes of this study, hypertension was determined by participants'
self-report of being diagnosed with hypertension and/or having abnormally high
blood pressure. Hypertension is considered a cardiovascular disease and is often
associated with diabetes mellitus.
Literacy level is the assessment of grade level reading ability. It can be measured by
instruments such as the Rapid Estimate of Adult Literacy in Medicine (REALM) (Davis
et al., 1993). Ninth-grade reading ability and higher is considered standard literacy
and eighth-grade reading ability and lower is considered low literacy.
Medication Education for purposes of this study included the need for patient to
receive guidance and/or training from a pharmacist on the following: proper use of
medication, patient self-care, medication adherence, use of monitoring devices,
disease state management and lifestyle changes.
Medication Therapy Management (or MTM) describes the services provided by
pharmacists to patients under which optimization of medication is used for the
improvement of health outcomes. For purposes of this study, the Medication
Therapy Management in Pharmacy Practice: Core Elements of an MTM Service
Model (version 2.0) (American Pharmacists Association & National Association of
Chain Drug Stores Foundation, 2008) served as the basis of MTM discussions.
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Sub-Optimal Medication Regimen for purposes of this study included sub-optimal
medication regimen included patients: needing additional drug information; having
been prescribed medication(s) that were insufficient or excessive in dose or
duration; having been prescribed medication(s) that are ineffective; needing more
cost effective drug option(s); under using medication(s); receiving unnecessary drug
therapy;

having poor drug administration technique;

using drugs excessively;

requiring additional laboratory monitoring; for whom additional drug therapy is
needed; and that have had adverse drug event(s).
Assumptions
The following assumptions were made for this study:
1. The Asthma Control Test is a valid and reliable instrument that measures a patient's
control of asthma.
2. The Modified Morisky Scale is a valid and reliable instrument that accurately
measures a patient's medication adherence.
3. The Newest Vital Sign is a valid and reliable instrument that accurately measures an
individual's health literacy level.
4. The Zung Self-Rating Depression Scale is a valid and reliable instrument that
accurately measures a patient's level of depression/anxiety.
5. The self-report items of age, years of education and race are accurate.
6. The self-report of being diagnosed with a particular disease(s) state is accurate.
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Significance
This study sought to gain additional information on the complex relationships between
the health literacy of patients with asthma, diabetes mellitus, cardiovascular disease and
depression/anxiety, and patient variables including age, gender, race, and levels of education.
Hundreds of studies have explored how patients' ability to read and comprehend healthcare
information is associated with poor health outcomes (Wallace, 2010) and there have been
pharmacist-led studies which have examined these same issues. However, there have been
few pharmacist-led MTM studies that have included the assessment of the health literacy of
patients. This study explores the relationship between the health literacy and the health
outcomes of those patients with chronic diseases who took part in a MTM program
administered as part of a university health wellness program.
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CHAPTER 2: CONCEPTUAL FRAMEWORK AND LITERATURE REVIEW
Introduction
This chapter introduces the conceptual framework that was used to guide the
construction of the study, including the Health Literacy Model and the Medication Therapy
Management Service Model. After the discussion of these models, relevant research literature
is presented on each of the study variables: health literacy, asthma, diabetes mellitus,
cardiovascular disease/hypertension, and depression/anxiety. For the literature review, a
comprehensive search of the literature was conducted using electronic search engines,
electronic databases, reviews of bibliographies of published research and manual searches of
journals and other publications. A graphic representation of the models used in this study will
be presented.
Conceptual Framework
Although the significance of low functional literacy on health outcomes had been
studied since the 1980s, it was not until 1995 that a landmark case highlighted the magnitude
of this issue. The case showed that up to two-thirds of patients seen in public hospitals in the
United States were unable to comprehend key health information on how to take medication
or how to schedule a follow-up appointment (Wallace, 2010; Williams, Parker, Baker, & al,
1995). As a result of this study and those that followed, in 2004, the Institute of Medicine
sought to document the problem of health literacy in the United States and to describe its
origins, consequences, and solutions.

As a result, Health Literacy: A Prescription to End

Confusion was published (Health literacy: A prescription to end confusion, 2004). This
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publication contained "Health Literacy Framework" and "Potential Intervention Points" (Figures
1 and 2, respectively).

Figure 1. Health Literacy Framework
(Health literacy: A prescription to end confusion, 2004)

Figure 2. Potential Intervention Points
(Health literacy: A prescription to end confusion, 2004)
Figure 2 shows literacy as the foundation of health literacy and health literacy as the
active mediator between individuals and health contexts (p. 32). Figure 2 illustrates the
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potential influence on health literacy as individuals interact with educational systems, health
systems, and cultural and social factors, and suggests that these factors could ultimately
contribute to health outcomes and costs (p.4). Figure 2 also indentifies three major areas of
potential intervention in effecting health literacy, namely culture and society, the health system
and the educational system.
The Institute of Medicine suggests that the U.S. educational system offers a primary
point of intervention in the improvement of literacy and health literacy (p. 142). In this section
of the report, the committee includes recommendations for K−12 education, the adult
education system, and education for health professionals.

With regard to healthcare

professionals, the committee recommends that professional schools in health fields, including
schools of pharmacy, incorporate health literacy into their curricula and areas of competence
(Recommendation 5-6, 2004, p. 161).
It is upon this basis that this study was undertaken; the results of this study will be used
to formulate educational materials for pharmacy education in the areas of health literacy and
the improvement of health outcomes for patients with chronic diseases.
Before discussing the literature related to health literacy and chronic conditions that are
addressed in this study (i.e. asthma, diabetes mellitus, cardiovascular disease, and depression),
a brief history of pharmacy education and Medication Therapy Management (MTM) is
presented, along with a review of selected laws involving pharmacists and MTM.
Pharmacy Education in the United States
Historically, students in the United States wishing to become licensed pharmacists
pursued baccalaureate degrees in pharmacy, generally through five-year programs. A student
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could (and can) attend a stand-alone college of pharmacy or a school of pharmacy housed
within a university. After decades of debate within the pharmacy community, in 1997, the
educational requirements of pharmacy programs increased (Accreditation Council for Pharmacy
Education, 2011). Beginning with 2005, those wishing to become licensed pharmacists must
now complete a Doctor of Pharmacy (Pharm.D.) professional degree. Today, all pharmacy
programs in the United States are professional doctorate programs.
Graduates who complete a Doctor of Pharmacy degree and wish to practice pharmacy
in the United States must become licensed. They must sit for and pass the North American
Pharmacist Licensure Examination (NAPLEX).

State boards of pharmacy require licensure

applicants from the United States to have graduated from an accredited Doctor of Pharmacy
program to be eligible to sit for the NAPLEX.
In the United States, Pharm.D. programs are accredited through the Accreditation
Council for Pharmacy Education (ACPE), founded in 1932 as the American Council on
Pharmaceutical Education. ACPE is an autonomous and independent agency whose board of
directors is appointed by the American Association of Colleges of Pharmacy, the American
Pharmacists Association, the National Association of Boards of Pharmacy and the American
Council on Education. ACPE's mission is "to assure and advance excellence in education for the
profession of pharmacy"(preamble) (Accreditation Council for Pharmacy Education, 2011) in
the United States, which it accomplishes, in great part, through its accreditation of U.S. schools
of pharmacy.
In 2006, the ACPE revised its accreditation standards to include provisions mandating
that schools of pharmacy include training in the patient-centered pharmaceutical care model
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(Accreditation Council for Pharmacy Education, 2011). This was the result of a paradigm shift
that had taken place in the profession as pharmacists sought to expand their roles past the
"mundane counting and pouring, licking and sticking" (Higby, 2010) (p. 112). Pharmacy students
are now trained to be drug information specialists and medication counselors. At the heart of
being an effective medication counselor is the concept of patient-centered pharmaceutical
care.
Pharmaceutical Care
According to the American Pharmacists Association, the definition of pharmaceutical
care is:
a patient-centered, outcomes oriented pharmacy practice that requires the pharmacist
to work in concert with the patient and the patient's other health care providers to
promote health, to prevent disease, and to assess, monitor, initiate, and modify
medication use to assure that drug therapy regimens are safe and effective.
Under this definition, pharmaceutical care is a form of pharmacy practice that is patientcentered rather than medication-centered. Pharmacists are required to accept responsibility as
direct patient-care providers and enter into a more formalized relationship with their patients
for the explicit purpose of improving patient outcomes (Cipolle, Strand, & Morley, 2004). This
type of patient-centered pharmaceutical care often includes Medication Therapy Management
services.
Medication Therapy Management
Academy of Managed Care Pharmacy (AMCP) has indicated that, for Medication
Therapy Management (MTM) to be effective, several things must occur, including: the
medication must be prescribed at the correct dose and the proper duration; the patient must
get the prescription filled and must be adherent to the therapy; patients must be monitored to
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ensure that the best health outcomes are achieved, that the objectives of the therapy are being
met, and that adverse events are minimized; and patients must be properly educated and
counseled.
This is especially true for patients who are at high risk as a result of chronic conditions
and/or complex medication regimens. MTM services greatly enhance patient care, leading to
improved overall health, while at the same time decreasing healthcare costs by reducing
improper medication use, preventing adverse drug events and supporting therapeutic goals
(Academy of Managed Care Pharmacy, 2006).
Pharmacist-led medication therapy reviews have shown to reduce the healthcare costs
for diabetic patients, including the reduction in physician visits and emergency department
visits (Cranor, Bunting, & Christensen, 2003; Garrett & Bulmi, 2005). Medication therapy
reviews have also shown to reduce asthma-related emergency room/hospital visits and
changes in asthma-related costs over time (Bunting & Cranor, 2006).
In 2004, eleven pharmacy organizations including the American Pharmacists Association
(APhA), the American Association of Colleges of Pharmacy, and the National Association of
Boards of Pharmacy achieved a consensus definition of MTM services as a distinct service or
group of services that optimize therapeutic outcomes for individual patients (American
Pharmacists Association & National Association of Chain Drug Stores Foundation, 2005).
Building on this consensus definition, the APhA and the National Association of Chain Drug
Stores Foundation developed a model framework for implementing effective MTM services in a
community pharmacy setting. This service model was later revised and memorialized in
Medication Therapy Management in Pharmacy Practice: Core Elements of an MTM Service
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Model Version 2.0. (American Pharmacists Association & National Association of Chain Drug
Stores Foundation, 2008).
The MTM service model in pharmacy practice 2.0 includes these five core elements:
Medication therapy review
Personal medication record
Medication-related action plan
Intervention and/or referral
Documentation and follow-up
A diagram of the MTM Service Model is presented in Figure 3 below. The "Medication Therapy
Review" element of the model has been highlighted as this is the area of inquiry of this study.

Figure 3. The Medication Therapy Management Core Elements Service Model
(American Pharmacists Association and The National Chain of
Drug Stores Foundation, 2008)
A "Medication Therapy Review" includes a systematic process of collecting patientspecific information, assessing medication therapies to identify medication-related problems,
developing a prioritized list of medication-related problems, and creating a plan to resolve
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them (p.344). The APhA and the National Association of Chain Drug Stores Foundation suggest
that medication therapy reviews include interviewing the patient to gather data including
demographic information, general health and activity status, medication history, and patient's
thoughts or feelings about his or her conditions and medication use (including medication
adherence) (American Pharmacists Association & National Association of Chain Drug Stores
Foundation, 2008).
Additionally, as part of a medication therapy review, assessing a patient's health literacy
level (Brown, 2006)—the education level of the patient, language differences, and other
characteristics of patient's communication ability that could affect health outcomes—proves
important. This is especially true for patients with chronic diseases such as asthma, diabetes
mellitus, cardiovascular disease/hypertension, and depression/anxiety which were the subjects
of this inquiry.
Laws associated with MTM services
An impetus for these organizations to develop a recognized model of MTM services was
the passage of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003.
This act, among other things, established Medicare Part D, which provides prescription drug
coverage for Medicare beneficiaries (seniors and persons receiving Social Security Disability
Insurance) through prescription drug plans. According to this law, all Part D plans must have a
MTM program (section 1860-4[c][1][2]). MTM programs target Medicare beneficiaries who
have multiple chronic diseases, are taking multiple drugs covered under Part D, and are likely to
incur annual drug cost exceeding a certain level (differs by year). The Centers for Medicare and
Medicaid Services (CMS) now require that all such MTM programs include an annual
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medication review, a person-to-person consultation (face-to-face or by telephone) and a
written summary ("Pharmacy educators utilize key partnerships to provide patient care," 2010).
This act also created unprecedented opportunity for pharmacists as the first federal law
specifically authorizing direct payment of pharmacists for MTM services, without being
"incident to" the services of a physician. In other words, pharmacist can now directly bill for
MTM services under their own set of billing codes (Hogue & Bluml, 2009). This recognizes the
valuable role that pharmacists play in improving the health outcomes of patients, especially
when it comes to MTM services.
MTM and pharmacy education
These same opportunities provide challenges for pharmacy education. MTM requires
the development of problem-solving skills and improved communication capabilities on the
part of pharmacy students. To be effective, pharmacy students must be taught how to
anticipate, prevent, and solve drug-related problems; identify which problems must be
attended to first (in cooperation with the patient); develop action plans that include non-drug
therapies; and be able to explain and justify these alternatives to patients, physicians, and third
parties (e.g. insurance companies). This requires a different skill set from those needed to
dispense medications (Berger, 2005, p.8).
To provide the requisite training for pharmacy students, educational materials about
MTM services need to be developed for pharmacy education. These materials should include
the demonstration of the relationships between health literacy, MTM services and health
outcomes of patients with chronic conditions.
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The following section presents relevant literature on health literacy and the
relationships of health literacy on the health outcomes for patients with asthma, diabetes
mellitus, cardiovascular disease, and depression.
Health Literacy
A two-year old is diagnosed with an inner ear infection and prescribed an antibiotic.
Her mother understands that her daughter should take the prescribed medication
twice per day. After carefully studying the label on the bottle and deciding that it
doesn’t tell her how to take the medication, she fills a teaspoon and pours the
antibiotic into her daughter's painful ear (Parker, Ratzan, & Lurie, 2003).
While this may be an extreme case, it highlights the importance of health literacy to
ensure appropriate health outcomes. Health literacy can be defined as the degree to which
individuals have the capacity to obtain, process and understand basic health information and
services needed to make appropriate health decisions (Ratzan & Parker, 2000). According to
the World Health Organization, "health literacy represents the cognitive and social skills which
determine the motivation and ability of individuals to gain access to, understand and use
information in ways which promote and maintain good health"(World Health Organization,
1998). Health literacy includes the ability to perform basic reading and mathematical tasks to
comprehend and act on health information such as prescription labels, appointment cards, and
hospital forms (Andrus & Roth, 2002).
Health literacy differs from general literacy, which refers to the basic ability to read,
write, and compute, without regard to context in which the reading or writing occurs (Mayer &
Villaire, 2007, p.17). Health literacy refers to how well a person applies a broad range of literacy
skills in the context of health care (Mayer & Villaire, 2007)(p.3). Many people with otherwise
acceptable general literacy may find it difficult to understand and act upon the concepts and
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vocabulary used in health-related contexts; therein lies the difference, especially in patient
populations with higher levels of education.
Presented with the issue of differing levels of health literacy among their patients,
pharmacists need to be in the position to educate and counsel patients in a comprehensive
way, identifying patients' level of understanding, and selecting appropriate educational
materials (Rantucci, 2007, p.7).
Health Literacy and Health Outcomes for Patients with Asthma
Asthma is a chronic inflammatory disease of the airways that affects more than 22
million people in the United States. According to the National Heart, Lung, and Blood Institute,
in spite of recent advances in the detection and prevention of asthma, asthma accounts for 2
million emergency visits per year and approximately 500,000 hospitalizations annually (National
Heart, 2007). In 2002, direct costs were estimated at $9.4 billion, with additional costs of $4.6
billion in indirect costs related to loss of work, loss of school days, and mortality (American Lung
Association Epidemiology and Statistics Unit Research and Scientific Affairs, 2004).
One of the hypotheses of the proposed study is that inadequate health literacy is
associated with clinical outcomes for patients with asthma, including the extent to which
patients know how to appropriately administer their medication.

In order to effectively

manage their asthma, patients must be knowledgeable about their disease and must be able to
use metered-dose inhalers (MDIs) correctly.

In a study examining the relationship of health

literacy to asthma knowledge and the ability to use metered-dosed inhaler, Williams, et al.
(1998) surveyed 483 patients presenting themselves either to an emergency room department
or routine care in a specialized asthma clinic. In accessing the patients' health literacy, they
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used the Rapid Estimate of Adult Literacy in Medicine (REALM). To assess the patients'
knowledge of asthma, they administered a 20-item oral questionnaire used in previous studies.
Proficiency in the use of an MDI was measured by requesting patients to demonstrate their
usual MDI technique of "taking two puffs" in the event of an asthma attack.
In this study, they found that only 27% of patients read at the high-school level,
although two-thirds reported being high school graduates; 33% read at the seventh-to-eighth
grade level, 27% at the fourth-to-sixth-grade level, and 13% at or below the third-grade level.
They found that reading level was the strongest predictor of asthma knowledge in a
multivariate analysis; in a multivariate regression analysis, reading level was the strongest
predictor of MDI technique. In sum, inadequate literacy was common and strongly correlated
with poorer knowledge of asthma and improper MDI use.
In 2006, Mancuso and colleagues explored the association between health literacy and
longitudinal outcomes in a cohort of asthma patients. They assessed the extent to which health
literacy and other variables were independently related to health outcomes, including physical
activity which is of interest in the proposed study. Patients within an urban setting were
eligible for participation in the study if they required daily asthma medications, such as inhaled
corticosteroids and were enrolled when they came in for scheduled office visits with their
primary care physician. Health literacy was measured with the Test of Functional Health
Literacy in Adults (TOFHLA) and overall asthma-related quality of life was measured with the
Asthma Quality of Life Questionnaire, a well-established scale measuring symptoms, activity
limitations, and the effects of emotions on asthma. Resource utilization for asthma was
measured by self-report of emergency room visits during three- month intervals.
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Of those who participated in this study, 82% had adequate health literacy, 8% had
marginal health literacy, and 10% had inadequate health literacy. In subsequent analyses, the
subjects were dichotomized into those with adequate health literacy (82%) and those with
marginal/inadequate health literacy. Although inadequate health literacy was associated with
worse quality of life, worse physical function, and more emergency department utilization, in
multivariable analysis, health literacy did not remain statistically significant with any of the
measured outcomes.
In 1991 the National Asthma Education and Prevention Program, coordinated by the
National Heart, Lung, and Blood Institute (NHLBI) published the Expert Panel Report: Guidelines
for the Diagnosis and Management of Asthma, which it updated in 1997, 2002 and 2007
(National Heart, 2007). Contained in these guidelines was the recommendation that patients
receive education to help improve the physician-patient partnership in managing patients'
asthma. Noting that no studies to date had evaluated the extent to which inadequate health
literacy served as a barrier to learn and retain asthma self-management skills (Berkman et al.,
2004), in 2005 Paasche-Orlow, et al. sought to examine the relationship between inadequate
health literacy and difficulties learning and retaining instructions about discharge medications
and appropriate MDI technique. The extent to which inadequate health literacy is associated
with the need for patient education is also the subject of this proposed study.
In exploring these variables, Paasche-Orlow, et al. recruited 73 adults who were
hospitalized for severe asthma at two inner-city academic medical centers.

At hospital

discharge, participants received intensive one-on-one, guideline-based written and oral
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instruction about their asthma discharge regimen as well as appropriate MDI technique. Health
literacy was measured with the Short Test of Functional Health Literacy in Adults
(S-TOFHLA) and participants were classified as having or not having inadequate health literacy.
In accessing patients' understanding of asthma medications (including inhaled corticosteroids),
the researchers developed an asthma knowledge scale. MDI technique was measured by
demonstration of the use of an MDI inhaler. In follow-up visits, these same items were reassessed. Additionally, asthma symptom control was measured using the Asthma Control
Questionnaire.
Of the 73 participants, 22% had inadequate health literacy. Before instruction,
inadequate health literacy was associated with lower asthma medication knowledge and worse
MDI technique (a form of medication adherence). However, inadequate health literacy was not
associated with difficulty in learning or retaining instructions about discharge regimen nor was
inadequate health literacy associated with difficulty in learning or retaining appropriate MDI
technique. The results of this study suggest that tailored patient education may reduce
disparities in asthma self-management.
MTM and health outcomes for patients with asthma
Exploring the theme of patient education and health outcomes for patients with
asthma, in their 2006 study, Bunting & Cranor assessed the clinical, humanistic, and economic
impact of a MTM program on adult patients with asthma living in and around Asheville, N.C.
This study was modeled after an earlier well-documented program entitled the Asheville Project
which examined a community-based pharmacist-driven diabetes care model. (The Asheville
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Project will be discussed under Health Literacy and Health Outcomes for Patients with Diabetes
Mellitus, below.)
In their quasi-experimental, longitudinal pre-post study, these researchers recruited
207 adult patients with asthma covered by two self-insured health plans—similar to the
proposed study site. They examined the impact of asthma education and regular long-term
follow-up by pharmacists, using scheduled consultations, monitoring, and recommendations to
physicians. Asthma education was provided by specially trained community pharmacists in one
or two individual one-on-one sessions, lasting 60-90 minutes each.
Patients were eligible to participate if they were covered by participating employers'
health plans and had a diagnosis of asthma, regardless of baseline control or severity of
disease. This study was unique as patients were not specifically targeted because of history of
emergency department visits, hospitalizations, or high utilization of health plan dollars.
Measured clinical outcomes included asthma severity, humanistic measures (i.e. how
asthma was affecting their lives), direct medical care costs (e.g. emergency room visits and
prescriptions), and indirect costs (i.e. cost to employer of lost work hours due to absenteeism)
over a period as long as five years. However, it is important to note that the patients' health
literacy level was not examined in this study.
The findings of the study were significant: All objective and subjective measures of
asthma control improved and were sustained for as long as five years. Asthma severity lessened
significantly, and emergency visits and hospitalizations significantly decreased. Spending on
asthma medications increased; however overall asthma-related medical claims decreased. This
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study is important as it shows the value of pharmacy-provided MTM services, including patient
education as the same relates to health outcomes for those patients with asthma.
The above cited study emphasizes the integral role that MTM services can play in
reducing overall healthcare costs and improving health outcomes of patients with asthma.
What makes this study unique is that health literacy levels of MTM patient participants were
measured to examine to what extent health literacy plays a role in predicting the health
outcomes of patients with asthma.
Health Literacy and Health Outcomes for Patients with Diabetes Mellitus
Societal changes in recent years have led to a dramatic increase in the prevalence of
obesity among adults and children in the United States. These changes include increased food
intake, nonhealthful foods, and physical inactivity. In 2007, 25.6% of the adults in the United
States were obese by self-report (Centers for Disease Control and Prevention). Obesity is a
major risk factor for cardiovascular disease, certain types of cancer, and type 2 diabetes
(Centers for Disease Control and Prevention). It is estimated that in 2010, diabetes affected
25.8 million people in the United States or 8.3% of the U.S. population; medical expenses for
those who have diabetes mellitus are more than two times higher than for people without the
disease (Centers for Disease Control and Prevention, 2011).
Given the complexity of managing diabetes mellitus, health outcomes for adults with
diabetes mellitus are better for those who can optimally incorporate self-management of their
diseases into their daily lives (Sigurdardottir, 2005).

Diabetes care requires an informed

individual who can seek, obtain, and comprehend information to engage in the management of
his/her health (Morris, MacLean, & Littenberg, 2006).

27
This study included patients with diabetes mellitus and helps determine if health literacy
is a factor in the management of their chronic condition. Along with levels of physical activity,
measurements of diabetes management included blood pressure, body mass index (BMI),
hemoglobin A1c (as an indication of glycemic control), triglycerides, and cholesterol levels. The
need for patient education in this population was also assessed.
Studies on health literacy and diabetes mellitus
To date, results of studies examining the relationship of health literacy and health
outcomes for patients with diabetes mellitus have been inconsistent. In an early study,
Williams (1998), examined the relationship between literacy and knowledge of chronic disease
focusing on patients with diabetes mellitus and hypertension. Drawing subjects from two urban
hospitals, the study enrolled 402 patients with hypertension and 114 patients with diabetes
mellitus. The patients' literacy level were tested using the TOFHLA; their knowledge of their
illness was assessed using 21 hypertension and 10 diabetes questions based on key elements in
educational materials used in their clinics. Other health outcomes measured in the study were
patients' levels of blood pressure and hemoglobin A1c.
These researchers found that 48% of the patients had inadequate functional health
literacy, and these patients had significantly less knowledge of their disease, important lifestyle
modifications, and essential self-management skills. For the diabetes patients in the study, this
finding was especially important because patients had attended formal educational classes on
diabetes; researchers realized that their educational strategies were not optimal with the large
number of patients with lower literacy. However, the researchers did not find a significant
relationship between literacy and levels of blood pressure or hemoglobin A1c.

28
In 2002, Schillinger et. al. investigated the association between health literacy and
diabetes outcomes in a cross-sectional study of 408 patients at two primary care clinics at a
university- affiliated hospital in San Francisco, Calif. The patients' health literacy level was
assessed using the short-form Test of Functional Health Literacy in Adults (s-TOFHLA). Health
outcomes measured in the study included patients' hemoglobin A1c level (as an indication of
glycemic control), self-report rates of retinopathy (diabetic eye disease), depression (as
measured by the Center for Epidemiologic Studies Depression Scale-10) and levels of social
support (as measured by questions from the Diabetes Care Profile). These researchers found
inadequate health literacy was independently associated with worse glycemic control and
higher rates of retinopathy, but did not find a significant relationship between health literacy
and the other health outcomes.
A recent study also reported conflicting results when studying health literacy and health
outcomes for those with diabetes mellitus. Osborn, Bains and Egede (2010) examined the
relationships between health literacy, determinates of health care, and glycemic control in 125
adults with type 2 diabetes. In this study, information collected included the patients' level of
health literacy (utilizing the Revised Rapid Estimate of Adult Literacy in Medicine), diabetes
knowledge and diabetes self-care (e.g. medication adherence, blood sugar testing, foot care).
Hemoglobin A1c levels came from patients' medical records. These researchers found no direct
relationship between health literacy and diabetes self-care or glycemic control. In a subsequent
analysis of the data, only diabetes knowledge was found to be significantly associated with
lower health literacy (Bains & Egede, 2011).
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Studies on MTM programs and health outcomes for patients with diabetes mellitus
MTM services have shown to improve health outcomes for patients with diabetes
mellitus. The most notable study is the Asheville Project (Cranor, et al., 2003). In that study,
investigators assessed the persistence of certain health outcomes for up to five years following
the initiation of community-based pharmaceutical care services for patients with diabetes.
Although health literacy levels of patients were not assessed, this study demonstrated the
benefit of pharmacy-led diabetes care program for its participants. Again, health literacy levels
will be established in the proposed study, adding an additional element in the evaluation of
MTM programs for patients with chronic conditions.
In their quasi-experimental, longitudinal pre-post study, Cranor and colleagues studied
the effects of patient education provided by certified diabetes educators, ongoing pharmacist
consultations, clinical assessments, and collaborative drug therapy management with
physicians. The main measured outcomes were changes in hemoglobin A1c and serum lipid
concentrations, as well as total medical utilization costs over time for 157 patients. As a result
of these interventions, the researchers found that mean A1c levels decreased at all follow-up
visits, with more than 50% of patients demonstrating improved levels each time. Additionally,
more than 50% showed improvements in lipid levels. Finally, total mean direct medical costs
decreased by $1,200 to $1,872 per patient per year compared to baseline expenditures.
Health Literacy and Health Outcomes for Patients with Cardiovascular Disease
In its 2010 publication Defining and Setting National Goals for Cardiovascular Health
Promotion and Disease Reduction: The American Heart Association's Strategic Impact Goal
Through 2020 and Beyond (Lloyd-Jones et al., 2010), the American Heart Association (AHA) set
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forth a new definition of cardiovascular health and outlined metrics needed to monitor health
over time.
In this document, the AHA indicated that ideal cardiovascular health should be defined
by the presence of both ideal health behaviors and ideal health factors. Included in ideal health
behaviors are nonsmoking, a low body mass index (BMI), certain levels of physical activity, and
a diet within prescribed guidelines. Although not included in the definition of ideal health
behaviors, the AHA also recognized the importance of lipid-lowering medications and
antihypertensive medications in reducing risks in patients with cardiovascular disease. These
medications can allow a patient to go from "poor cardiovascular health" to "intermediate
cardiovascular health" (as defined in the report and discussed below). The AHA also
acknowledged the importance of monitoring medication adherence in those patients taking
medications as better adherence has shown to improve health outcomes.
In outlining ideal health factors, the AHA indicated that adults should have untreated
total cholesterol of less than 200 mg/dL, untreated blood pressure of diastolic less than 120
over less than 80 mm Hg., and fasting blood glucose less than 100 mg/dL. Taking into
consideration both ideal health behaviors and ideal health factors, under these guidelines
patients can be categorized as having poor, intermediate or ideal cardiovascular health.
Both ideal health behaviors and ideal health factors were measured in this study.
Measurements of health behaviors for patients with cardiovascular disease included BMI (as an
indicator of proper nutrition) and the levels of physical activity. Adherence to medication
regimen was also assessed as a health behavior using the Modified Morisky Scale (Morisky, et
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al., 1986). Health factors included measurements of cholesterol, blood pressure, and fasting
blood glucose levels.
Studies on health literacy, cardiovascular disease, and health behaviors
Perhaps the largest and most documented study dealing with health literacy and chronic
conditions, including cardiovascular disease, has become known as the Prudential Study. As of
2010, eight articles using the Prudential data have been published by various authors including,
Baker, Gazmararian, Howard, and Wolf (Berkman et al., 2011). All of these articles utilize
information obtained from approximately 3,000 members in the Prudential Medicare plan with
enrollees in Cleveland, Ohio; Houston, Texas; and Tampa, Fla., and south Florida.
Participants in the Prudential Study completed a one-hour in-person interview in their
home. Survey items included demographics, current and past smoking behaviors, BMI
measurement, chronic conditions (e.g. hypertension, diabetes mellitus, heart failure, and
asthma), and self-rated physical and mental health functioning. Patients were excluded from
the study if it was determined they were not comfortable speaking English or Spanish, were
blind, or had limited cognitive functioning (e.g. they did not know their address, year they were
born or the current year or month) (Wolf, Gazmararian, & Baker, 2005). In assessing health
literacy, the researchers used the short version of the Test of Functional Health Literacy in
Adults (s-TOFHLA)(Baker, Williams, Parker, Gazmararian, & Nurss, 1999).
Using the Prudential data, Wolf, et al. (2005) found that enrollees with inadequate
health literacy were significantly more likely to report having heart failure and/or diabetes;
were more likely to have limitations in instrumental activities of daily living; and had lower
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mental health. However, in a subsequent study, they found no significant difference in the BMI
of those patients with inadequate health literacy (Wolf, Gazmararian, & Baker, 2007).
With regard to adherence to cardiovascular medication within this same group,
Gazmararian et al. (2006) found no significant association between health literacy levels and
medication refills. Although, those with inadequate health literacy skills had increased odds of
low refill adherence compared with those with adequate health literacy skills.
In order to have a diet within the suggested AHA guidelines, patients need to be able to
read and interpret food nutrition labels.

This involves not only reading skills, but basic

numeracy skills (e.g. ability to perform basic math). In a cross-sectional study of 200 adult
patients in an academic primary-care clinic, Rothman et al. (2006) examined the relationship of
health literacy and the understanding of food labels. These researchers used the Rapid Estimate
of Adult Literacy in Medicine (REALM) (Davis, et al., 1993) to measure literacy and the Wide
Range Achievement Test (3rd ed.) (Wilkinson, 1993) to measure numeracy. The ability to
understand food labels was assessed using a Nutrition Label Survey which the researchers
developed for the study.
These researchers found that lower literacy and numeracy levels were highly correlated
with poorer performance on the Nutrition Label Survey. In fact, even patients with higher
literacy could have difficulties interpreting labels. In analyzing the results of their study,
common reasons for incorrect answers included misapplication of serving size, confusion due to
extraneous material on the label, and incorrect mathematical calculations.
In examining patients' ability to manage their medications, including the ability to
identify, open, describe the dose, and describe the timing of their cardiovascular medications,
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Kripalani, et al. (2006) found those with inadequate health literacy significantly less likely to
identify all of their medications, compared with those with adequate health literacy. No
significant difference was found between inadequate health literacy and other components
(e.g. being able to open container, indicate dose, and report timing).
One notable study examined a pharmacist-led intervention designed to increase
medication adherence in patients with heart failure. In a randomized control trial, Murray, et al.
(2007) measured adherence to those medications commonly used by such patients including
ACE inhibitors, beta-blockers, and diuretics by patients in a university-affiliated, inner-city
ambulatory care practice.

Medication adherence was measured several ways including self-

reported adherence (through the use of Morisky Medication Adherence Scale), refill adherence
(using prescription records), and the use of electronic prescription container lids (devices that
record the time and date of each opening and closing of a prescription container). Health
literacy, however, was not measured.
As was the case in this study, the pharmacists-led intervention included a medication
history of all prescription and over-the-counter medications and dietary supplements taken by
the patients. Additionally, the pharmacists provide patient-centered verbal instructions, written
instructions, and medication containers containing medication category icons (e.g., a red ace of
hearts for ACE inhibitors). The same icon appeared in the written directions and container
labels and lids to improve medication identification.
These researchers found that taking and refill adherence were greater in the
intervention group during the nine-month intervention period, but adherence dissipated with
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subsequent follow-up visits. However, emergency department visits and hospital admissions
lessened and annual direct healthcare costs were lower in the intervention group.
Studies on health literacy, cardiovascular disease, and health indicators
As mentioned above, health indicators for those with cardiovascular disease include the
measurement of levels of cholesterol, blood pressure, and blood glucose. Studies examining
the relationship of health literacy and these indicators are also inconsistent. (As studies
exploring these health indictors in diabetic patients have already been outlined in Studies on
health literacy and diabetes mellitus, above, this section will focus on studies examining
patients with hypertension, a form of cardiovascular disease.)
A 2009 cross-sectional study explored the association between health literacy levels,
hypertension control (measured by blood pressure) and knowledge (Pandit et al., 2009). In this
study, 330 patients with hypertension were recruited from six primary care safety net clinics in
Grand Rapids, Mich.; Chicago, Ill.; and Shreveport, La. Participants were given the s-TOFHLA to
access their health literacy; hypertension knowledge was measured by asking patients a series
of questions about the characteristics and symptoms of high blood pressure. Blood pressure
was taken from the medical records and considered controlled if it was below 140 mmHg for
diastolic and below 90 mmHg for systolic (or <130 mmHg/<80 mmHg for patients with diabetes
mellitus). These researchers found lower health literacy was significantly associated with a
lower probability of having controlled blood pressure.
Powers, et al. conducted a similar study with different results (2008). For their study,
these researchers pooled data from patient interviews performed at the time of enrollment for
two separate randomized controlled trials to improve blood pressure control. The first
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underlying study was the Veteran Study to Improve the Control of Hypertension, conducted at
three VA medical primary care clinics in Durham, Va. The other participants were enrolled in
Duke University Health Care System's Take Control of Your Blood Pressure study. To assess
literacy, the Rapid Estimate of Adult Literacy in Medicine (REALM) (Davis, et al., 1993) was given
to all participants and blood pressure readings were abstracted from the individuals' medical
record. Additionally, self-reported medication adherence was assessed using the Morisky scale
(Morisky, et al., 1986). When looking at both groups of patients, these researchers found no
significant difference in blood pressure control among those with lower literacy compared to
those with higher literacy.
One study sought to determine if a nurse-administered, patient-tailored intervention
could improve blood pressure control in a group of 294 veterans taking hypertension
medication (Bosworth et al., 2005). As a part of this study, the health literacy of the patients
was measured using the REALM (Davis, et al., 1993). If patients had lower levels of health
literacy, their hypertension medication regimen was explained to them verbally, in effort to
increase patients' knowledge and medication adherence. After the first six months of the
study, of those patients receiving the nurse-led intervention, there was no significant increase
in patients' knowledge of hypertension or medication adherence.
Next, empirical literature about health literacy and patients with depression and
anxiety will be presented.
Health Literacy and Health Outcomes for Patients with Depression/Anxiety
Compared with the literature examining the relationships between health literacy and
asthma, diabetes, and cardiovascular disease, there are fewer studies that examine health
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literacy, depression and anxiety. Of those studies that have explored these variables, many of
them involve patients with HIV/AIDS (Kalichman et al., 2008; Murphy et al., 2010; Nokes et al.,
2007) or Latinos with limited English skills (Bennett, Culhane, McCollum, & Mathew, 2007;
Coffman & Norton, 2010). However, for purposes of this study, they have limited applicability.
However, there are two studies relevant to the proposed study. Sudore, et al. (2006)
assessed the prevalence of limited health literacy and comorbid conditions associated with
limited health literacy, including depression.

As a part of the Health, Aging and Body

Composition (Health ABC) Study, these researchers administered the Center for Epidemiologic
Study Depression Scale (Radloff, 1977) to 2,512 well-functioning black and white Medicareeligible men and women. Drawing participants from Pittsburgh, Pa., and Memphis, Tenn., the
health literacy level of the patients was measured using the REALM (Davis, et al., 1993).
Information on the health status of the patients, including certain comorbid diseases such as
cardiac disease, stroke, hypertension, and diabetes mellitus was obtained using a variety of
data sources including clinical data obtained at yearly study examinations. These researchers
found that patients with lower health literacy had significantly worse health status, including
hypertension, diabetes, obesity, and depression.
Conversely, as a part of the Prudential Study described earlier, Howard, Gazmararian &
Parker (2005) explored the relationship of health literacy and self-reported depression. In their
analysis of 3,260 managed care patients, they found no significant relationship between
inadequate health literacy and depression.
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Conclusion
The role of pharmacists in the United States is changing. No longer are pharmacists only
responsible for dispensing medication; now, pharmacists are required to accept responsibility
as direct patient-care providers and enter into a more formalized relationship with their
patients for the explicit purpose of improving patient outcomes (Cipolle, et al., 2004). This type
of patient-centered pharmaceutical care often includes Medication Therapy Management
(MTM) services. Going forward, through providing MTM services, pharmacists will be in the
position to help improve the health outcome of patients with chronic diseases such as asthma,
diabetes mellitus, cardiovascular disease, and depression. However, in order to do this most
effectively, pharmacists must be aware of the health literacy level of their patients and be
aware of the relationships between health literacy and health outcomes of those patients with
chronic conditions.
To provide the requisite training for pharmacy students, educational materials about
MTM services must be developed for pharmacy education. These materials need to include the
demonstration of the relationships between health literacy, MTM services and health outcomes
of patients with asthma, diabetes mellitus, cardiovascular disease/hypertension, and
depression/anxiety. As will become clear in Chapter 3 below, this study's methodology was
designed to build on existing knowledge in these areas to assist in the development of such
materials.
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CHAPTER 3: METHODS
Introduction
This study is a secondary analysis of data previously collected as a part of an
investigation entitled Medication Therapy Management and Health Literacy Assessment
through Health Horizons: Manage My Medications (hereinafter, Manage My Medications).
Started in 2008, the Manage My Medications study was part of Healthy Horizons, a health
wellness program at Butler University in Indianapolis, Ind. Butler University's Institutional
Review Board approved the Manage My Medications study on August 28, 2008 (Appendix B)
and its continuance (Appendix C). Data from Manage My Medications was supplied to this
investigator in the form of a de-identified dataset whereby the subjects were not identified
either directly or through identifiers linked to the subjects. The proposed investigation was
submitted to Wayne State University's Human Investigation Committee for approval as
"Exempt" (Appendix A).
Study Site
In 2004, in collaboration with Butler University's College of Pharmacy and Health
Sciences (COPHS) and Butler's Department of Human Resources, Healthy Horizons was
established with the mission of improving the health and well-being of Butler's faculty and staff.
As of part its mission, Healthy Horizons provides comprehensive, confidential health screening
and patient education aimed at improving patient outcomes. In an effort to decrease the
overall financial impact of rising healthcare costs (including medication), in 2007, Butler
University became self-insured.

Along with this change came an imperative to contain

medication costs, especially for faculty and staff with chronic conditions.
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Armed with de-identified prescription medication claims data of Butler employees from
the previous year, in 2008, Healthy Horizons identified the medications most frequently
prescribed for covered employees. Based on this data, Healthy Horizons began an MTM
program aimed at those Butler employees taking medications for chronic conditions including
asthma, diabetes mellitus, cardiovascular disease/hypertension, and depression/anxiety. The
Manage My Medications study was based on this MTM program.
Subject Recruitment
Criteria for admission into Manage My Medications included: (a) being enrolled in
Butler University's health insurance plan [including spouses and domestic partners]; (b) ability
to sign the consent form; (c) ability to complete the study instruments with a minimum of
assistance; and (d) taking at least one monthly prescription medication(s) for the treatment of
asthma, diabetes, hypertension, depression/anxiety, hyperlipidemia, heartburn/GERD,
hypothyroidism, or taking four or more chronic prescription medications. Additionally, subjects
had to be at least 18 years of age. Exclusion criteria included: (a) pregnancy; (b) having utilized
Health Horizon's services in the past twelve months; and (c) unwillingness to make the required
visits, which included baseline and one follow-up visit after six months.
Persons who met the inclusion criteria were invited to participate in the study. If they
were interested, they were provided with study details, which include information on an
incentive gas card valued at $50. Those who agreed to participate signed an informed consent
form and were enrolled in the study.
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Data Collection
Approximately 90 subjects were enrolled in Manage My Medications. Data were
collected on demographic, psychosocial, and physical functioning using instruments designed
by Healthy Horizons for the program and standard assessment instruments. Additionally,
certain clinical tests were performed to assess and gain an understanding of the control of
patients' disease state(s). These data were collected at the date of enrollment in the study.
Data collection points were baseline upon entry into the study and at six months. This study
only examined baseline data.
Study Design
The study was a cross-sectional study to investigate associations of levels of health
literacy and various demographic and health-related outcomes. The research question was
operationalized as two specific aims and corresponding research hypotheses which were
presented in Chapter I.
After assessing base-line differences among health literacy levels, univariate analyses
were conducted to determine associations between study variables utilizing the chi-squared
test of association for categorical variables and t-tests for continuous variables. Significance
was set at the 5% level for a two-sided test. All testing was conducted using commercially
available statistical software (e.g. SAS). Finally, a logistical regression model was constructed to
predict inadequate health literacy, using variables assessed in the previous step. The logistical
regression model allowed for determination to what extent any particular variable is an
independent predictor of inadequate health literacy, controlling for other variables in the study.
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Operationalization of the Study Variables
As discussed in Chapter II, the variables of interest for this study were conceptually
derived from Health Literacy Framework (Health literacy: A prescription to end confusion, 2004)
and The Medication Therapy Management Core Elements Service Model (American Pharmacists
Association & National Association of Chain Drug Stores Foundation, 2008).

Within this

framework, health literacy is identified as the study variable. This investigation examined the
associations of health literacy and the following factors: (a) age, gender, race, and levels of
education;

(b)

clinical

outcomes

of

asthma,

diabetes

mellitus,

cardiovascular

disease/hypertension and depression/anxiety, (c) medication adherence, (d) the need for
patient education and (e) sub-optimal medication regimens.

The operationalization of the

concepts and their associated measures are presented in Table 1.
instruments measuring these variables follows.

A discussion of the
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Table 1. Operationalization of Study Variables
Operationalization of Study Variables
Concept
Variable
Measure
Health Literacy
Health Literacy
The Newest Vital Sign
_____________________________________________________________________________________
Patient Variables
Age
Age at entry into Manage My
Medications
___________________________________________________________
Gender
Self-report of gender
___________________________________________________________
Race
Self-report of race/ethnicity
___________________________________________________________
Education
Self-report of years of formal
education
_____________________________________________________________________________________
Health Outcomes
Asthma Control
Self-Report with Asthma
Control Test
_________________________________________________________________
Diabetes Mellitus
1. Self-Report
2. Blood pressure
3. Fasting blood glucose test
4. Test for the following:
triglycerides, Total
cholesterol (TC), high
density lipoprotein (HDL),
and low density
lipoprotein (LDL).
5. Body Mass Index (BMI)
___________________________________________________________
Cardiovascular Disease
1. Self-Report
2. Blood Pressure
3. Body Mass Index (BMI)
4. Fasting blood glucose test
___________________________________________________________
Depression
Self-report with Zung
Depression Scale
___________________________________________________________
Medication Adherence
Patient Interviews and Self-Report with
Modified Morisky Medication Scale
___________________________________________________________
Patient Education
Patient interviews
___________________________________________________________
Optimal Medication Regimen Patient interviews
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Health Literacy
Health literacy, as previously defined, is the degree to which individuals have the
capacity to obtain, process and understand basic health information and services needed to
make appropriate health decisions (Ratzan & Parker, 2000). There are multiple instruments that
can measure health literacy. As previously mentioned, these tests include the Rapid Estimate
of Adult Literacy in Medicine (REALM) and the Test of Functional Health Literacy in Adults
(TOFHLA) (Baker, et al., 1999; Davis, et al., 1993). Newer tests have been developed to assess
health literacy, including The Newest Vital Sign (Weiss, et al., 2005).
For the Manage My Medications investigation, The Newest Vital Sign was used to
measure health literacy. One of the strengths of The Newest Vital Sign is that it tests both
reading comprehension and the ability to make calculations (numeracy) (Mayer & Villaire,
2007). Additionally, when compared to other tests, The Newest Vital Sign is very quick to
administer; it takes only 3 minutes to assess health literacy. Finally, The Newest Vital Sign is
available in both English and Spanish.
The Newest Vital Sign uses the nutrition label from the back of a carton of ice cream as
the testing vehicle. Patients are given a copy of the nutrition label and asked six questions,
several of which require them to make mathematical calculations. For example, one of the
questions asks, "If you usually eat 2500 calories in a day, what percentage of your daily value of
calories will you be eating if you eat one serving?" To answer the question correctly, the patient
must refer to the label, note that there are 250 calories in each serving, and divide this 250
(calories in one serving) by 2,500 (usual calories in a day) to come up with the correct answer of
10 percent. The total number of correct answers is the patient's health literacy score, with a
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total possible score being 6 points. A score of 0-1 suggests high likelihood of limited literacy, a
score of 2-3 indicates the possibility of limited literacy, and a score of 4-6 almost always
indicates adequate literacy. The Newest Vital Sign is presented in Appendix D. For purposes of
this study, scores were broken down into two groups: those having limited health literacy
(scores 0-3) and those having adequate health literacy (scores 4-6)
Patient Variables
Patient variables such as age, gender, race, and levels of education were assessed by
questions posed to the patients by the interviewer/pharmacist and answers were recorded on a
multi-page Data Collection form, which was developed by Healthy Horizons for the study.
Existing medical conditions (e.g. asthma, diabetes, cardiovascular disease/hypertension,
depression/anxiety) were recorded, along with the number of prescriptions per month and
amounts spent each month on prescription medications. Patients' health literacy score on The
Newest Vital Sign were also recorded on the Data Collection form. The Data Collection form is
presented in Appendix E.
Asthma Control
As mentioned earlier, asthma is an inflammatory lung disease (Poureslami, et al., 2007)
and is considered a common chronic disorder of the airways which is characterized by, among
other things, recurring airflow obstruction (National Heart, 2007). According to the National
Heart, Lung and Blood Institute, effective asthma management includes the development of an
individual treatment plan aimed at minimizing symptoms, proper use of medications,
preventing limitations in work and other physical activity, and preventing acute attacks
(National Heart, 2007). However, level of asthma control is often overstated by both patients
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and physicians, resulting in missed work or school and increased use in healthcare services
(Nathan, 2004). Therefore, the American Lung Association recommends everyone 12 years of
age or older with asthma be assessed for asthma control (QualityMetric Incorporated, 2002).
In the Manage My Medications study, for those patients reporting being diagnosed with
asthma, control over their condition was measured using the Asthma Control Test
(QualityMetric Incorporated, 2002). The Asthma Control Test (ACT) consists of a series of five
questions, each worth 5 points, with a total possible score of 25. The questions presented in the
ACT not only measure how often patients use asthma medications (e.g. metered-dose inhalers),
but also assesses the functional impact of asthma on patients' daily lives. For example,
question number one on the ACT asks, "In the past 4 weeks, how much of the time did your
asthma keep you from getting as much done at work, school or at home?" (emphasis supplied).
A score of 19 points or less on the ACT indicates that a patient's asthma may not be controlled
as well as it could be. The Asthma Control Test is presented in Appendix F.
Depression
As noted earlier, those patients with chronic conditions such as diabetes and
cardiovascular disease may also suffer from depression.

In order to assess the rate of

depression in those patients participating in the Manage My Medication study who reported
being diagnosed with depression or anxiety, the researchers administered the Zung Self-Rating
Depression Scale (Zung, 1965). The Zung Self-Rating Depression Scale consists of 20 statements
with a value of 1-4 correlating to each response. Statements include: "I feel down-hearted and
blue," "I get tired for no reason," "I feel hopeful about the future," and "I feel I am still useful
and needed." In response to each statement, patients indicate: "a little of the time" (1 point),
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"some of the time" (2 points), "good part of the time" (3 points), or "most of the time" (4
points). Most people with depression score between 50 and 69; the highest possible score is
80. The Zung Self-Rating Depression Scale is presented in Appendix G.
Medication Adherence
Adherence is the extent to which a person's behavior (in terms of taking medications,
following diets, or executing lifestyle changes) coincides with medical or health advice
(Meichenbaum & Turk, 1987). Measuring medication adherence (e.g. taking correct medication
in the correct amount at the correct time) is an integral part of the The Medication Therapy
Management Core Elements Service Model (American Pharmacists Association & National
Association of Chain Drug Stores Foundation, 2008). As such, patients' medication adherence
was measured as a part of the Manage My Medications study.
For the study, medication adherence was measured of all participants using the
Modified Morisky Scale (Morisky, et al., 1986). Based on an earlier version, the Modified
Morisky Scale measures a patient's motivation to take their medication and their knowledge
about their medications. Both of these factors help explain the intention of the patient to
adhere to their medication regimen. For those patients with chronic diseases, medication
adherence is of particular importance.
The Modified Morisky Scale consists of six questions, with three questions measuring
motivation and three questions measuring knowledge. For the motivation domain, each "no"
answer (questions 1, 2 and 6) receives a score of 1 and each "yes" answer receives a score of 0.
This provides a range of motivation scores of 0 to 3. A score of 0 to 1 in this domain indicates
low motivation; a score greater than 1 indicates high motivation. For knowledge (questions 3, 4
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and 5) a score of 0 to 1 indicates low knowledge and a score greater than 1 indicates high
knowledge. Motivation scores and knowledge scores are combined to determine the patient's
overall adherence level (total possible of six points). The Modified Morisky Scale is presented in
Appendix H.
Optimal Medication Regimen and Need for Patient Education
A significant part of any medication therapy management (MTM) program is the review
of all of the patient's medications (both prescriptions and over-the-counter) and a
pharmacist/patient consultation. This is the hallmark of the patient-centered pharmaceutical
care model. As stated earlier, MTM's are designed to improve collaboration among
pharmacists, physicians, and other healthcare providers; enhance communication between
patients and their healthcare team; and optimize medication use for improved patient
outcomes (American Pharmacists Association & National Association of Chain Drug Stores
Foundation, 2008).
As part of the Manage My Medications MTM program, patients were asked to bring in
all of their prescription and over-the-counter medications when they came in for their
scheduled interview. A series of health screenings, including blood pressure, body mass index
(BMI), cholesterol, and fasting blood glucose were performed on each patient.
During their consultation, all of the patient's medications were reviewed for the
following potential problems: additional therapy needed, unnecessary therapy, drug
interactions, adverse effects, insufficient dose/duration, excessive dose/duration, ineffective
drug, administration/technique, more cost effective options, excessive use, and under use.
Based on the consultation, the need for health education and/or medical education was
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also identified and patient specific education was proffered when needed. All of this
information was recorded on the Data Collection form and kept as a part of the patient's
confidential medical record. All medical records were/are stored in compliance with all federal
(e.g. HIPPA) and state laws.
Based on the above, a personalized health wellness plan was then developed for each
patient, including recommendations on disease management. Patients were given the option
to have the results of their MTM consultation (including health screenings) sent to their
physician(s).

Recommended changes in medication were also sent to physicians when

requested by the patient. Finally, a six-month follow-up appointment was scheduled for each
patient.
Summary
This chapter has presented an overview of the Medication Therapy Management and
Health Literacy Assessment through Healthy Horizons: Manage My Medications investigation
from which data will be used to answer the specific aims of the proposed study. Information on
the study site, subject recruitment, data collection, study design, study variables and their
measures has been presented. Results of the analysis and discussion of the findings will be
presented in following chapters.
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CHAPTER 4: RESULTS
Introduction
In this chapter, the results of the Medication Therapy Management and Health Literacy
Assessment through Healthy Horizons: Manage My Medications investigation are presented.
Following a description of the participants (including the health outcomes measured in this
study), the results of the regression analyses are reported.
Description of the Participants
Socio-Demographics
A total of 90 participants took part in the MTM study. Slightly more women (N=52;
57.78%) than men (N=38, 42.22%) participated. With regard to race, seventy-nine of the
participants self-identified as Caucasian (87.78%), nine participants (10.0%) self-identified as
African-American, and two participants (2.22%) self-identified as being Hispanic.
The participants ranged in age from 27 to 71, with a mean age of 50.4 years (SD= +
11.58). Participants in the study were grouped into ten-year categories. Four (4.44%) were 2029 years of age, ten (11.11%) were 30-39, 27 (30.0%) were 40-49 years old, 25 participants
(27.78%) were between 50 and 59, 18 (20.0%) were 60-69, and two (2.22%) were 70 years of
age or older. (Age was missing for four of the participants.)
When considering the years of formal education, the data revealed that eight (8.89%)
completed high school, ten (11.11%) attended some college, 28 (31.11%) completed bachelors
degrees, 23 (25.56%) had a master's degree, and 21 (23.33%) had received a doctoral degree.
The socio-demographics of the study population can be found in Table 2 below.
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Table 2. Socio-Demographics of the Study Population (N=90)
Socio-Demographics of the Study Population (N=90)
Characteristic
Gender
Female
Male

52
38

57.78
42.22

Race
African American
Caucasian
Hispanic

9
79
2

10.00
87.78
2.22

4
10
27
25
18
2

4.44
11.11
30.00
27.78
20.00
2.22

Highest education level completed at entry of study
High school
Some college
Bachelors degree
Masters degree
Doctorate degree

8
10
28
23
21

8.89
11.11
31.11
25.56
23.33

Health Literacy Score
Limited (0-3)
Adequate (4-6)

10
80

11.11
88.12

Age at time of entry of study (years)
20-29
30-39
40-49
50-59
60-69
70+
(missing ages for four participants)

N

%
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Health Outcomes of Participants
As a part of the MTM program, various health outcomes of the participants were
measured. These assessments included:
(a) Participants' self-report of being diagnosed with a specific condition(s) (e.g. asthma,
diabetes, hypertension);
(b) Physiologic outcomes (e.g. blood pressure, total cholesterol, fasting blood glucose,
body mass index);
(c) Results of standardized self-report measures (e.g. Asthma Control Test, Zung
Depression Scale, Morisky Medication Adherence Scale);
(d) Patient interviews assessing the need for patient education (e.g. proper use of
medication, medication adherence, use of monitoring devices); and
(e) Patient interviews identifying sub-optimal drug regimens (e.g. unnecessary drug
therapy, excessive dose/duration, additional drug therapy needed).
The results of these assessments are discussed below by specific health outcome.
Asthma
Of the 90 participants, twelve (13.3%) patients reported having being diagnosed with
asthma. When these twelve patients were administered the previously described Asthma
Control Test, nine of these patients (or 75%) scored <19 points, indicating that their asthma
may not be controlled as well at it could be.
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Diabetes mellitus
Of the 90 participants in the study, 11 (12.22%) reported having been diagnosed having
pre-diabetes and nine (10.0 %) reported having being diagnosed as having either type 1 or type
2 diabetes mellitus. Of those who had type 1 or type 2 diabetes mellitus, 55.6% (N=5) had both
fasting blood glucose levels that were not in optimal range (>70 and <130 mg/dL) and low
density lipoprotein (LDL) levels not within optimal range (>70 and 100mg/dL).
Cardiovascular disease/hypertension
Over a third of the participants (N=33; 36.67%) reported having being diagnosed with
hypertension. Blood pressure readings were taken of these 33 patients; it was found that 27
(81.82%) did not have their blood pressure under control (>140/90 mm Hg). Of those patients
not reporting having being diagnosed with hypertension, blood pressure readings indicated that
three participants (3.33%) had pre-hypertension (> 120/90 mm Hg).
Body mass index
A body mass index or BMI (as described in Chapter 1) was calculated for all participants
in the study. A BMI <25 is considered normal, > 25 is considered overweight, and > 30 suggests
obesity, a risk factor for diabetes mellitus and cardiovascular disease. In this study, 38.89%
(N=35) of the participants had BMI's indicating that they were overweight and 35.56% (N=32)
had BMI's indicating obesity.
Fasting blood glucose levels for those patients NOT self-reporting diagnosis of pre-diabetes or
type 1 or 2 diabetes
Similar to the BMI test, all participants were administered a fasting blood glucose test,
including those patients who did not report being diagnosed with pre-diabetes or type 1 or 2
diabetes mellitus. For non-diabetes patients, fasting blood glucose levels of 100-125 mg/dL
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indicate pre-diabetes, and fasting blood glucose levels of > 125 suggests diabetes. For those
participants that did not report being diagnosed with either pre-diabetes or diabetes, 20
(28.57%) had fasting blood glucose levels indicating pre-diabetes and 1 patient (1.43%) had a
blood glucose level indicating diabetes mellitus.
Dyslipidemia
Dyslipidemia (or abnormal cholesterol levels) is associated with diabetes mellitus and
heart disease. Ideally, a patient's total cholesterol level should be <200 mg/dL, their high
density lipoprotein (HDL or "good" cholesterol) should be >40 mg/dL, and their triglycerides
should be <150 mg/dL. With regard to low density lipoprotein (LDL or "bad" cholesterol), LDL
levels of >130 mg/dL indicate moderate risk for cardiovascular disease and LDL levels of <100
mg/dL indicate high risk.
In this study, 47 participants (52.22%) reported having been diagnosed with
dyslipidemia (or abnormal cholesterol levels). Of these 47 patients, 13 (27.66%) had higher
than normal total cholesterol levels; 16 (34.0%) had both sub-optimal HDL levels and higher
than normal triglycerides. Twenty-one participants (44.68%) had LDL levels indicating having
moderate risk and nine participants (19.15%) had LDL levels indicating a high risk of
cardiovascular disease.
Depression/anxiety
Of the 90 participants, 27.8% (N=25) reported having being diagnosed with depression
or anxiety. These patients (reporting a diagnosis of depression or anxiety) completed the Zung
Self-Rating Depression Scale. Of these 25 participants, five patients (20%) scored > 50 points on
the Zung Self-Rating Depression Scale indicating the presence of depression.
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Adherence
As mentioned in Chapter 1, adherence concerns the extent to which a person's behavior
(in terms of taking medications, following diets, or executing lifestyle changes) coincides with
medical or health advice (Meichenbaum & Turk, 1987). Measuring medication adherence (e.g.
taking correct medication in the correct amount at the correct time) is an integral part of The
Medication Therapy Management Core Elements Service Model (American Pharmacists
Association & National Association of Chain Drug Stores Foundation, 2008). Similar to other
tests already mentioned, all participants in the study were administered Modified Morisky
Adherence Scale to help determine how adherent they were with their medication regimen. Of
the 90 participants in the study—all of whom were taking at least one medication—19 (21.11%)
had scores indicating sub-optimal adherence to their medication regimen.
Need for patient education
As a part of this medication therapy management (MTM) study, patient interviews were
conducted to help identify specific areas in which patients needed education regarding their
medication and lifestyle. All participants (N=90; 100%) needed some form of patient education
and these needs were stratified into six different categories: education about medication,
additional information, help with disease management, help with monitoring devices,
education about self-care, and life-style counseling. In particular, of these 90 participants, 85
(94.44%) needed education on the proper use of their medication, while 58 patients (64.44%)
needed additional information on adherence to their medication regimen.

Seventy-one

(78.89%) needed help with the management of their disease(s), and 15 (16.67%) needed help
with monitoring devices (e.g. blood glucose testing, blood pressure monitoring). Fifty-one
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patients (56.67%) needed education regarding self-care, while 80 (88.89%) needed counseling
on lifestyle changes.
Identification of sub-optimal drug regimens
Patient interviews done as a part of the MTM program helped identify specific problems
with patients' medication regimens, these problems being broadly defined as "sub-optimal drug
regimens." Patients were asked to bring with them to the interview all medications that they
had been prescribed along with any over-the-counter medications they were taking. Patient
interviews revealed that 75 study participants (83.33%) had some type of sub-optimal drug
regimen issue. Sub-optimal drug regimens were broken down into 12 categories.
Of the 75 patients found having sub-optimal drug regimens, three participants (4.0%)
had unnecessary medications and two (2.67%) were taking ineffective drugs. With regard to
dose and duration of drug therapy, five participants (6.67%) had excessive dose/duration, while
13 (17.33%) had insufficient dose/duration. Two of the patients (2.67%) were found taking
excessive amounts of their medication(s) and nine (12.0%) were under utilizing their
medication. Four patients (5.33%) reported adverse events relating to their drug regimens, two
patients (2.67%) needed additional information on their medications, and five patients (6.67%)
needed additional or follow-up laboratory monitoring.

Further, of the 75 patients with sub-

optimal drug regimens, 25.33% (N=19) were found to have exhibited ineffective administration
of their medication and 28.0% (N=21) needed additional medications. Finally, 46.67% (N=35)
were prescribed medication(s) for which there was a more cost effective (cheaper) option.
A summary of the health outcome measures of the patient population is set forth in
Table 3 below.
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Table 3. Health Outcomes Measures of Patient Population (N=90)
Health Outcomes Measures of Patient Population (N=90)
Characteristic
Asthma
Self-reporting having asthma: Yes
Asthma not controlled (< 19 Asthma Control score): Yes

N

%

12
9

13.33
75.0

11
9

12.22
10.0

5

55.56

5

55.56

33
27

36.67
81.82

3

5.3

Body Mass Index (BMI)
Overweight (BMI > 25 - <30 kg/m2): Yes
Obese (BMI > 30 kg/m2): Yes

35
32

38.89
35.56

Fasting Blood Glucose (for those not reporting being
diagnosed with pre-diabetes or diabetes)
Pre-diabetes (100-125 mg/dL): Yes
Diabetes (>125 mg/dL): Yes

20
1

28.57
1.43

47
13
16
16

52.22
27.66
34.0
34.0

21
9

44.68
19.15

Diabetes Mellitus
Self-report having pre-diabetes: Yes
Self-report having type 1 or type 2 diabetes: Yes
Blood glucose level not
within optimal range (>70 - <130 mg/dL): Yes
Low density lipoprotein not within
optimal range(LDL) (>70 mg/dL - < 100mg/dL): Yes
Cardiovascular Disease/Hypertension
Self-report having hypertension: Yes
Blood pressure not controlled (>140/90 mm Hg): Yes
Blood Pressure (for those not reporting having hypertension)
Pre-hypertension (> 120/90 mm Hg.): Yes

Dyslipidemia (abnormal cholesterol level)
Self-report having dyslipidemia: Yes
Total cholesterol (> 200mg/dL): Yes
High density lipoprotein (HDL) (< 40mg/dL): Yes
Triglycerides (> 150mg/dL): Yes
Low density lipoprotein (LDL)
Moderate risk (<130 mg/dL): Yes
High risk (<100 mg/dL): Yes
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Table 3 Health Outcomes Measures of Patient Population (N=90), cont.
Characteristic
N

%

Depression/Anxiety
Self-report having depression/anxiety: Yes
Evidence of depression (> 50 Zung score): Yes

25
5

27.78
20.0

Less adherence to medication regimen (<3 Morisky score)

19

21.11

Need for patient education (assessed by interview)
Proper use of medication
Medication adherence
Disease state management
Use of monitoring devices
Patient self-care
Lifestyle changes

90
85
58
71
15
51
80

100.0
94.44
64.44
78.89
16.67
56.67
88.89

Sub-optimal medication regimen (assessed by interview)
Unnecessary therapy: Yes
Ineffective drug: Yes
Excessive dose/duration: Yes
Insufficient dose/duration: Yes
Excessive use of drug: Yes
Under use of drug: Yes
Adverse events: Yes
Need for drug information: Yes
Requires additional lab monitoring: Yes
Ineffective administration technique: Yes
Additional therapy needed: Yes
Ineffective drug option (cost): Yes

75
3
2
5
13
2
9
4
2
5
19
21
35

83.33
4.0
2.67
6.67
17.33
2.67
12.0
5.33
2.67
6.67
25.33
28.0
46.67
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Analysis of Research Questions by Specific Aims
As presented in Chapter 1, this study was guided by one research question, which was
operationalized as three specific aims with corresponding hypotheses. The following section
will present the analysis for each of these three specific aims.
Specific Aim Number One
1. To evaluate the association of health literacy with the following demographic factors:
gender, race, age, and level of education.
H1a: Limited health literacy is associated with higher age and lower levels of education.
H1b: Limited health literacy is not associated with gender or race.
The health literacy level of the participants was measured using the previously
described instrument, The Newest Vital Sign. For this study, patients were categorized by
having limited health literacy (scoring 0-3 on The Newest Vital Sign) or having adequate health
literacy (scoring 4-6). Looking at the population as a whole, 11.11% (N=10) had limited health
literacy, with the remaining 88.89 % (N=80) demonstrating scores of adequate health literacy.
Of the women in the study (N=52), three (5.76%) had limited health literacy, while 49
(94.24%) had adequate health literacy. For the males in the study (N=38), seven (18.42%) had
limited health literacy, while 31 (81.58%) had adequate health literacy. The difference in
proportions in the two groups was significant at the p<0.05 level (p=0.049).
When analyzed by race, of the nine participants who self-identified as African
Americans, 33.33% had limited health literacy, while six (66.77%) had adequate health literacy.
Caucasians represented 87.77% (N=79) of the study population; of this group, 8.86% (N=7) had
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limited health literacy, while 91.14% (N=72) had adequate health literacy. (Because of the
potential for loss of confidentiality when N<6, Hispanic participants were excluded from this
analysis.) Limited health literacy among African Americans and Caucasians was not found to be
statistically significant.
When analyzed by age, those between the ages of 20-29 years (N=4), and 30-39 (N=10),
all (100%) had adequate health literacy. For the group 40-49 years of age (N=27), 3.70% had
limited health literacy; 96.30% had scores indicating adequate health literacy. For those 50-59
years of age (N=25), 12.0% had limited health literacy, while 88.0% had adequate health
literacy. For participants between the ages of 60-69 years (N=18), 22.22% had limited health
literacy and 77.78% had adequate health literacy. Because of the potential for loss of
confidentiality when n<6, those 70 and older were excluded. When analyzed by groups of ten
years, age was not found to be statistically significant.
When considering the years of formal education, for those who had completed high
school (N=8; 8.9%), 50% had limited health literacy and 50% had scores indicating adequate
health literacy. For those with some college (N=10; 11.1%), all (100%) had adequate health
literacy. Participants with a bachelors degree (N=28; 31.1%) were divided between 10.71%
having limited health literacy and 89.29% having adequate health literacy. Of those with a
masters degree (N=23; 25.6%) 4.34% had limited and 95.56% had adequate health literacy. For
those having a doctoral degree (the highest education level of the group), 9.52% had scores
indicating limited health literacy, while 90.48% had adequate health literacy. Among these
groups, there was a significant association between education level and limited health literacy
(p=0.024). A summary of these findings can be found in Table 4 below.
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Table 4. Characteristics of Study Population by Health Literacy Level (N = 90)
Characteristics of Study Population by Health Literacy Level (N = 90)
Limited
Health
Literacy
Score 0- 3
(N)

Adequate
Health
Literacy
Score 4- 6 (N)

N
(Total)

% Having
Limited Health
Literacy

10

80

90

11.11

Female

3

49

52

5.76

Male

7

31

38

18.42

3

6

9

33.33

Characteristic

Total Population

Test
Statistic*

Significance**

Not Applicable

Gender

Race
African
American
Caucasian
Hispanic

7

72

79

8.86

***

***

***

***

2

Χ (7.00)

0.049

LR (4.04)

0.133

LR (8.91)

0.113

Age entering study (years)
20 - 29

0

4

4

0

30 - 39

0

10

10

0

40 - 49

1

26

27

3.70

50 -59

3

22

25

12.0

60 -69

4

14

18

22.22

***

***

***

***

70+
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Table 4 Characteristics of Study Population by Health Literacy Level (N = 90), cont.
Limited
Health
Literacy
Score 0 – 3
(N)

Adequate
Health
Literacy
Score 4 – 6
(N)

N
(Total)

% Having
Limited Health
Literacy

Test Statistic
*

Significance**

High School

4

4

8

50.0

LR (11.20)

0.024

Some College

0

10

10

0

Bachelor Degree

3

25

28

10.71

Masters Degree

1

22

23

4.34

Doctoral Degree

2

21

21

9.52

Characteristic

Highest education
level completed at
entry of study

2

Note(s): *Test statistic is either the Χ (Chi-squared Test of Association) or the LR (Likelihood Ratio); Fisher's Exact Test
(2-sided) used when assumptions for Chi-squared Test were violated.
** Tested at the 95% level (p-value <0.05)
*** Results suppressed due to having fewer than 6 individuals in a socio-demographic cell.

A separate analysis was done to understand the relationship between limited health
literacy and age. Participants were stratified by age into two groups: those who <50 years of
age (N=43) and those >50 years of age (N=43) (with ages for four participants were missing
from the data). For those who were <50, only 2.3% had limited health literacy. For those who
were > 50 years, 18.6 % had limited health literacy. With these two groups, there was a
significant association between age and limited health literacy (Χ2 =6.08; p-value= 0.02). Figure
4 illustrates health literacy scores by those <50 and those > 50 years of age.
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Figure 4. Limited Health Literacy by Age Group
Specific Aim Number Two
2. To evaluate the association of health literacy with clinical outcomes of patients with
asthma, diabetes mellitus, cardiovascular disease, and depression.
H2a: Limited health literacy is associated with clinical outcomes of asthma, diabetes
mellitus, cardiovascular disease, and depression/anxiety.
H2b: Limited health literacy is associated with higher body mass index (BMI), higher
blood pressure, higher fasting blood glucose levels, and dyslipidemia.
H2c: Limited health literacy is associated with lower medication adherence.
H2d: Limited health literacy is associated with the need for patient education.
H2e: Limited health literacy is associated with sub-optimal medication regimens.
Asthma
Of those participants in the study who reported being diagnosed with asthma (N=12),
two (16.67%) had limited health literacy, while ten (83.33%) had adequate health literacy.
These same patients were administered the Asthma Control Test. Of the asthma patients who
scored <19 points on the Asthma Control Test (indicating that their asthma may not be
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controlled) (N=9), two (22.22%) had limited health literacy and seven (77.78%) had adequate
health literacy. There was no association found among either group with regard to health
literacy levels.
Diabetes Mellitus
Of the total population, 11 patients self-reported having been diagnosed with prediabetes (12.22%); one person of this group (9.09%) had limited health literacy. Nine
participants (10.0%) of the study reported being diagnosed with type 1 or type 2 diabetes. Of
those having type 1 or type 2 diabetes 11.11% (N=1) had limited health literacy. There was no
association found between limited health literacy and being diagnosed with either pre-diabetes
or type 1 or type 2 diabetes mellitus.
Those patients who reported being diagnosed with type 1 or type 2 diabetes were
administered blood glucose and LDL cholesterol tests. Of the five patients whose blood glucose
was not within optimal range (>70 - <130 mg/dL), all (100%) had adequate health literacy.
Similarly, of those five patients whose LDL was not within optimal range (>70 - < 100 mg/dL), all
(100%) had adequate health literacy.
Cardiovascular Disease/Hypertension
As stated above, over a third of the participants (N=33; 36.67%) reported having been
diagnosed with hypertension. Of those 33 participants, 18.18% (N=6) had limited health
literacy. To help gauge whether their blood pressure was under control, blood pressure
readings were taken of these 33 patients; it was found that 27 (81.82%) did not have their
blood pressure under control (>140/90 mm Hg). Of this group of 27, the data revealed that
22.22% (N=6) had limited health literacy, while 77.78% had adequate health literacy levels.
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Of those patients not reporting having being diagnosed with hypertension, blood
pressure readings indicated that three participants (3.33%) had pre-hypertension (> 120/90 mm
Hg). All three of these participants (100%) had adequate health literacy. None of the groups
mentioned in this Cardiovascular Disease/Hypertension section were statistically associated
with limited health literacy.
Body Mass Index
A body mass index (BMI) was calculated for all participants in the study and 38.89%
(N=35) of the participants had BMI's indicating that they were overweight (BMI >25 kg/m2). Of
this group, 14.28% (N=5) had limited health literacy, while the remaining 85.72% (N=30) had
adequate health literacy scores. Of those whose BMI's indicated obesity (BMI > 30 kg/m2),
6.25% (N=32) had limited health literacy. Neither group showed a statistical association with
health literacy.
Fasting Blood Glucose Levels for Patients NOT Self-Reporting Diagnosis of Pre-Diabetes or Type
1 or 2 Diabetes
All participants were administered a fasting blood glucose test, including those patients
who did not report being diagnosed with pre-diabetes or type 1 or 2 diabetes mellitus. For
patients not being diagnosed with diabetes mellitus, fasting blood glucose levels of 100-125
mg/dL indicate pre-diabetes, and fasting blood glucose levels of > 125 suggests diabetes. For
those participants that did not report being diagnosed with either pre-diabetes or diabetes, 20
(28.57%) had fasting blood glucose levels indicating pre-diabetes. Of this group 15.0% (N=3)
had limited health literacy. One patient (1.43%) had a blood glucose level indicating diabetes
mellitus and this person's score on the Newest Vital Sign showed adequate health literacy. No
associations were found among these groups and health literacy scores.
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Dyslipidemia
In this study, 47 participants (52.22%) reported having been diagnosed with
dyslipidemia; 8.51% of these (N=4) had limited health literacy, while 91.49% had adequate
health literacy. Of these 47 patients, 13 (27.66%) had higher than normal total cholesterol
levels and 15.38% of these patients (N=2) had limited health literacy. Of this same group of 47,
16 (34.0%) had both sub-optimal HDL levels and higher than normal triglycerides. For those
with sub-optimal HDL levels and higher than normal triglycerides, 6.25% (N=1) had limited
health literacy.
Again, of the same group of 47 participants reporting being diagnosed with
dyslipidemia, 21 patients (44.68%) had LDL levels indicating having moderate risk for heart
disease; 9.52% of those (N=2) had limited health literacy. Finally, those in this group showing
high risk for cardiovascular disease (LDL <100 mg/dL) (N=9), all had scores indicating adequate
health literacy. No associations were found among these groups and health literacy scores.
Depression/Anxiety
Of the 90 participants, 27.8% (N=25) reported having being diagnosed with depression
or anxiety. Only one of these patients (4.0%) was found to have limited health literacy. Of
these 25 patients, five (20%) scored > 50 points on the Zung Self-Rating Depression Scale
indicating the presence of depression. All five of these members had adequate health literacy.
Adherence
All participants in the study were administered Modified Morisky Adherence Scale to
help determine how adherent they were with their medication regimen. Of the 90 participants
in the study—all of whom were taking at least one medication—19 (21.11%) had scores < 19
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points on the scale, indicating sub-optimal adherence. Of this group, 5.26% (N=1) had limited
health literacy, the remaining 94.74% (N=18) had scores > 4 on the Newest Vital Sign indicating
adequate health literacy.
Need for Patient Education
As mentioned above, patient interviews were conducted to help identify specific areas
in which patients needed education, including issues involving their drug regimens and lifestyle.
All participants (N=90; 100%) needed some form of patient education. Eighty-five participants
(94.44%) needed education on the proper use of their medication; it was found that 9.41%
(N=8) of these patients had limited health literacy. Of those patients who could benefit from
education on self-care (i.e. non-medication related improvements, like avoiding problematic
foods) (N=51), 11.76% (N=6) had limited health literacy scores.
For those needing education on medication adherence (N=58; 64.44%), 12.07% (N=7)
had limited health literacy. Of the population who could benefit from education on improved
use of health monitoring devices (N=15;16.67%), one person (6.67%) had limited health
literacy.

Seventy-one (78.89%) of the participants needed education on disease state

management (e.g. seeking regular laboratory tests, monitoring blood pressure). Of this group,
11.26% (N=8) had scores indicating limited health literacy.
The last category of the need for education was on lifestyle changes, including need for
additional physical exercise and/or weight loss. Eighty-eight participants in the study (88.89%)
needed assistance in this area. Of these 88, the data revealed that 12.50% (N=10) of them had
limited health literacy, while the remaining 87.50% had scores on the Newest Vital Sign
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indicating adequate health literacy. Of all of these sub-groups within Need for Patient
Education, no statistical significance was found with limited health literacy scores.
Identification of Sub-Optimal Drug Regimens
Patient interviews also conducted as a part of this medication therapy management
study helped identify specific problems with patients' medication regimens, with these
problems being labeled "sub-optimal drug regimens." Patient interviews revealed that 75 study
participants (83.33%) had some type of sub-optimal drug issue. The sub-optimal drug regimen
area was broken down into 12 categories.
Of these 75 patients having sub-optimal drug regimens, three participants (4.0%) were
taking unnecessary medications, and 33.33% (N=1) of this group had limited health literacy.
Two participants (2.67%) were prescribed ineffective medications; both had adequate health
literacy. With regard to dose and duration of drug therapy, five participants (6.67%) had drug
regimens of excessive dose/duration,; all had adequate health literacy. On the other hand, 13
(17.33%) patients had drug regimens involving insufficient dose or duration, of which one
(7.69%) had limited health literacy.
Two of the patients (2.67%) were found taking excessive amounts of their
medication(s); both patients had adequate health literacy scores. Of the nine patients (12.0%)
who were under utilizing their medication, 11.11% (N=1) had limited health literacy. Four
patients (5.33%) reported adverse events relating to their drug regimens and two patients
(N=4; 2.67%) needed additional information on their medications. Of both these groups, 50%
had limited health literacy (N=2 and N=1, respectively). The study found that five patients
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(6.67%) needed additional or follow-up laboratory monitoring, of which 40% (N=2) had limited
health literacy levels.
Further, of the 75 patients with sub-optimal drug regimens, 25.33% (N=19) were found
to have exhibited ineffective administration of their medication, with 5.26% (N=1)
demonstrating limited health literacy. Twenty-one patients (28.0%) were found to be in need of
additional medications; 9.52% (N=2) of this group had limited health literacy. Finally, 46.67%
(N=35) were prescribed medication(s) for which there was a more cost effective (cheaper)
option. Of these 35 patients, 2.86% (N=1) had scores showing limited health literacy.
Of all of these sub-groups within this Sub-Optimal Medication Regimen section, no
statistical significance was found with limited health literacy.
Summary of Aim Number Two
Limited health literacy was not found to be associated with any of the variables analyzed
in Aim Number Two: clinical outcomes of asthma, diabetes, mellitus, cardiovascular
disease/hypertension, and depression/anxiety; higher body mass index (BMI), higher blood
pressure, higher fasting blood glucose levels, and dyslipidemia; lower medication adherence;
the need for patient education; and sub-optimal medication regimens. A summary of these
findings can be found in Table 5, below.
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Table 5. Health Outcome Measure of Study Sample by Health Literacy Level (N = 90)
Table 5 Health Outcome Measures of Study Sample by Health Literacy Level (N = 90)
Limited
Adequate
%
Health
Health
Having
N
Test
Characteristic
Literacy
Literacy
Limited
(Total)
Statistic*
Score 0-3
Score 4-6
Health
(N)
(N)
Literacy
Asthma
Self-reporting having
2
2
10
12
16.67
Χ (0.433)
asthma: Yes
Asthma not controlled
2
(<
19
Asthma
2
7
9
22.22
Χ (1.250)
Control Score): Yes
Diabetes Mellitus
Self-report having
pre-diabetes
Self-report having
type 1 or type 2
diabetes: Yes
Blood glucose level
not
within
optimal range (>
70 and < 130
mg/dL): Yes
Low
density
lipoprotein not
within optimal
range (LDL) (> 70
and
<
100
mg/dL): Yes

0.617
0.261

2

1.000

2

1.000

2

0.444

2

0.444

2

0.162

2

0.157

2

1.000

1

10

11

9.09

Χ (0.052)

1

8

9

11.11

Χ (0.000)

0

5

5

0

Χ (1.406)

0

5

5

0

Χ (1.406)

27

33

18.18

Χ (2.638)

26

27

22.22

Χ (2.934)

3

3

0

Χ (0.000)

Cardiovascular Disease/Hypertension
Self-report
having
6
hypertension: Yes
Blood
pressure
not
controlled (>140/90
6
mm Hg): Yes
Blood Pressure (for those not reporting
a diagnosis of hypertension)
Pre-Hypertension
(> 120/90 mm
0
Hg): Yes

Significance**
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Table 5: Health Outcome Measures of Study Sample by Health Literacy Level (N = 90), cont.
Limited
Adequate
%
Health
Health
Having
N
Test
Characteristic
Literacy
Literacy
Limited
(Total)
Statistic*
Score 0-3
Score 4-6
Health
(N)
(N)
Literacy
Body Mass Index (BMI)
Overweight (BMI > 25
5
30
35
14.28
LR (1.307)
2
& < 30 kg/m ): Yes
Obese (BMI > 30
2
30
32
6.25
2
kg/m ): Yes
Fasting Blood Glucose
(for those not reporting a diagnosis of
pre-diabetes, or diabetes)
Pre-Diabetes ( 100 3
125 mg/dL)
Diabetes ( > 125
0
mg/dL)
Dyslipidemia
Self-report
of
dyslipidemia: Yes
Tot Cholesterol (>
200 mg/dL): Yes
HDL (< 40mg/dL):
Yes
Triglycerides (> 150
mg/dL): Yes
LDL
Moderate Risk (<130
mg/dL): Yes
High
Risk
(<100
mg/dL): Yes
Depression
Self-report having
depression: Yes
Evidence
of
depression (> 50
Zung Depr’n Scale)

17

20

15.0

LR (0.523)

1

1

0

4

43

47

8.51

X (0.674)

2

11

13

15.38

X (1.091)

1

15

16

6.25

X (0.159)

1

15

16

6.25

X (0.159)

2

19

21

9.52

X (0.050)

0

9

9

0

X (1.035)

1

24

25

4.0

Χ (1.772)

0

5

5

0

Χ (0.662)

Significance**

0.520

0.770

2

0.510

2

0.304

2

1.000

2

1.000

2

1.000

2

0.574

2

0.273

2

1.000
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Table 5: Health Outcome Measures of Study Sample by Health Literacy Level (N = 90), cont.
Limited
Adequate
%
Health
Health
Having
N
Test
Characteristic
Literacy
Literacy
Limited
(Total)
Statistic*
Score 0-3
Score 4-6
Health
(N)
(N)
Literacy
Less
adherence
to
2
medication regimen
1
18
19
5.26
Χ (0.834)
(< 3 Mod-Morisky)
Need
for
patient
education
Proper
use
of
medication
Patient self-care
Medication adherence
Use of monitoring
devices
Disease
state
management
Lifestyle changes

2

10

80

90

11.11

Χ (0.000)

8

77

85

9.41

Χ (4.47)

2

1.000

2

1.000

2

0.595

11.76
12.07

Χ (0.051)
2
Χ (0.152)

1

14

15

6.66

Χ (0.360)

8

63

71

11.26

Χ (0.000)

12.50

0.930

2

51
58

80

1.000

1.000
1.000

45
51

70

0.682

2

6
7

10

Significance**

Χ (1.406)

Sub-optimal medication
2
7
68
75
9.33
Χ (1.440)
0.361
regimen
Unnecessary
drug
2
1
2
3
33.33
Χ (1.552)
0.301
therapy: Yes
2
Ineffective drug: Yes
0
2
2
0
Χ (0.256)
1.000
Excessive
2
0
5
5
0
Χ (0.662)
1.000
dose/duration: Yes
Insufficient
2
1
12
13
7.69
Χ (0.180)
1.000
dose/duration: Yes
Excessive use of drug:
2
0
2
2
0
Χ (0.256)
0.613
Yes
2
Under use of drug: Yes
1
8
9
11.11
Χ (0.000)
1.000
2
Adverse events: Yes
2
2
4
50.0
Χ (6.410)
0.059
Need
for
drug
2
1
1
2
50.0
Χ (3.132)
0.211
information: Yes
Requires
lab
2
2
3
5
40.0
Χ (4.474)
0.093
monitoring: Yes
Ineffective
admin.
2
1
17
19
5.26
Χ (0.008)
1.000
technique: Yes
Additional
drug
2
2
19
21
9.52
Χ (0.070)
1.000
therapy needed: Yes
Ineffective drug option
2
1
34
35
2.86
Χ (3.951)
0.082
(cost): Yes
Note(s):
*: Test statistic is either the Χ2 (Chi-squared Test of Association) or the LR (Likelihood Ratio).
Fisher's Exact Test (2-sided) used when assumptions for Chi-squared Test were violated.
**: Tested at the 95% level (p-value < 0.05).
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Specific Aim Number Three
3. To construct a logistical regression model to determine independent predictors of
health literacy from among the variables considered in research questions 1 and 2, above.
H3: Each of the following will independently predict health literacy: gender, age, race,
level of education, health outcomes of asthma, diabetes mellitus, cardiovascular
disease, and depression/anxiety, lower medication adherence, increased need for
patient education, and sub-optimal medication regimens.
A logistic regression model was constructed to assess potential predictors of health
literacy. Candidate variables were entered into the regression model, then removed through
backwards (conditional) step-wise regression. The variables that remained after the final step
were: gender, age, education, self-reported diagnoses of asthma, hypertension and
dyslipidemia. This final model was highly significant (-2LL = 28.596; p < 0.001) and significant
variance explained (Nagelkerke R2 = 0.869). All of these remaining variables were significant.
These findings can be found in Table 6.
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Table 6. Logistic Regression
Logistic Regression
Model: Predictors of Limited Literacy (Score 0 - 3)

1,2,3

95% CI for Odds Ratio
Variable

β(SE)

Gender
Age (> 50)
4
Education
Asthma
Hypertension
Dyslipidemia
Notes:

1.

2.
3.
4.

4.21(1.60)
4.43(1.79)
3.298(1.47)
-5.76(1.61)
-3.48(1.52)
2.64(0.93)

Lower
2.970
2.501
1.515
0.000
0.002
13.852

Odds Ratio

Upper

67.628
83.599
27.069
0.003
0.031
1.295

1,539.77
2,794.00
483.767
0.374
0.603
148.152

Significance
(p-value)
0.008
0.013
0.025
0.018
0.022
0.030

Stepwise, backwards elimination (conditional), logistic regression model was completed. All
variables were entered into the model with the remaining variables left after selection criteria
were analyzed through 9 steps.
2
Model Assessment: -2LL = 28.596 (p-value < 0.001); Nagelkerke R = 0.869.
Overall model correctly classifies limited literacy in 91.9% of cases.
Education was recoded to be dichotomous (Graduate Degree/ Less than Graduate Degree).

Summary
In this chapter, the statistical analysis for the study was presented. A description of the
participants included socio-demographics of the population and health outcomes. Each of the
three specific aims of the study were examined, including a regression analysis model setting
forth the predictors of limited health literacy for the population. In the next chapter, these
results will be discussed, along with the implications for future research and pharmacy
education.
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CHAPTER 5: DISCUSSION
Introduction
The purpose of this study was to examine the extent to which health literacy was
associated with different demographic factors (e.g. gender, race, educational level) in a welldefined, self-insured population and to examine the extent to which health literacy was
associated with clinical outcomes of those patients taking medications for certain chronic
conditions. Other patients were identified through this MTM study with conditions that had
previously gone undiagnosed.
The primary aim of this study was to test the hypothesis that health literacy, alone or in
combination with other factors, was associated with certain clinical outcomes of patients with
asthma, diabetes mellitus, cardiovascular disease/hypertension, and depression/anxiety.
Health outcomes were measured using: participants' self-report of diagnosis with a specific
condition(s); physiological outcomes (e.g. blood pressure, body mass index, and fasting blood
glucose); results of standardized self-reporting measures (e.g. Asthma Control Test, Zung
Depression Scale); pharmacist-led patient interviews assessing the need for patient education
(e.g. proper use of medication, use of monitoring devices); and pharmacist-led patient
interviews identifying sub-optimal drug regimens (e.g. unnecessary drug therapy, additional
medications needed).
The findings of this study will be used in the development of case studies for pharmacy
education, supporting the inclusion of issues of health literacy into doctor of pharmacy
(Pharm.D.) curriculum. To adequately prepare future pharmacists, colleges of pharmacy need
to include training on the relationships between literacy and health (Youmans & Schillinger,
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2003). Additionally, the findings of this study can help employers address issues associated
with limited health literacy and chronic disease state management, thereby reducing
healthcare costs and improving the health outcomes of their employees.
In this chapter, the findings of this investigation are discussed using the
operationalization of study variables as an organizing framework. Conclusions drawn from the
findings are presented, as are the implications for pharmacy education. Finally, the significance
and limitations of the study are discussed and recommendations for future research are
delineated.
Health Literacy and Socio-Demographics of Participants
Gender
Of the 90 participants in the study, there were slightly more women (57.78%) than men
(42.22%). Of the men in the study, 18.42% had limited health literacy, scoring 0-3 on The
Newest Vital Sign, while only 5.76% of the women in the study had similar scores. The
difference in the proportion of these two groups was found to be statistically significant at the
p<.05 level (p=0.049). When a logistical regression analysis was conducted for all variables in
the study, gender was found to be a predictor of limited health literacy. These findings were
consistent with at least one other study that showed an association between men and lower
literacy levels (Davis, Wolf, Bass, Tilson, et al., 2006)
Though the scope of the study prevents explaining this circumstance fully, two potential
explanations come to mind. First, in the U.S. women hold primary responsibility for family
healthcare decisions, which might be a contributing factor in women participants’ somewhat
greater health literacy. Second, differences in limited health literacy scores between males and
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females in this study may relate to the test instrument, The Newest Vital Sign. Although found
to be a valid and reliable instrument, The Newest Vital Sign tests a participant's health literacy
by having each participant answer certain questions while examining a nutrition label of an ice
cream. As U.S. women do much of the food shopping, men may not be as accustomed to
reading food nutrition labels, which reduces their health literacy scores.
Race
It was not surprising that in this study there were a higher number of Caucasians
(87.78%) than any other racial group. This could be attributed to there being few African
American or Hispanic faculty members and staff at the study institution.
Of the Caucasian population, 8.86% had scores indicating limited health literacy, while
33.33% of African Americans (N=3) had scores indicating limited heath literacy. (Health literacy
scores for Hispanics were suppressed due to having fewer than six individuals in that sociodemographic category.) Race was not found to be statistically associated with limited health
literacy. The logistical regression model constructed also supported the hypothesis that race
would not be a predictor of health literacy in this study population.
Age
The average age of participants was 50 years, with ages ranging from 27 to 71 years. In
the first analysis, participants in the study were grouped into ten-year categories. Within these
ten-year categories, age was not found to be associated with limited health literacy. However,
when ages were stratified into those who were <50 years of age and those >50 years of age,
there was a significant association between age and limited health literacy (p-value= 0.02). This
finding is in keeping with the general understanding that older patients are more likely to have
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lower literacy skills (Kutner, et al., 2006) and that limited health literacy is more common in
older people with chronic conditions, including hypertension, diabetes mellitus, obesity and
depression (Sudore, et al., 2006). This finding also has importance as older Americans
comprise an increasingly larger portion of the population and consume 2-3 times more
medication than the general public (Davis, Wolf, Bass, Middlebrooks, et al., 2006). Given this,
future pharmacists need to be aware of the association of health literacy and older patients,
especially with those with chronic conditions.
Education
In looking at the data of this MTM study regarding education, for those patients whose
highest level of formal education was high school, 50% had limited health literacy. This finding
was in keeping with the general understanding that those patients with lower education
attainment often have lower literacy.
For those participants in the study with some college (less than a bachelors degree),
none had limited health literacy. For those with a bachelors degree, 10.71% had limited health
literacy; of those with a masters degree, 4.34% had limited health literacy. Interestingly, for
those having a doctoral degree, the number of patients with limited health literacy scores
increased to 9.52%. This increase seems counterintuitive, but it is consistent with other studies
showing years of higher education do not equate to literacy skill (Kirsch, Jungeblit, Jenkins, & al,
1993; Sudore, et al., 2006).
As stated earlier, there was a significant association between education level and health
literacy. In the logistical regression model, education was found to be predictor of health
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literacy in this study. These findings were in support of the pertinent parts of H 1a and H3 stated
in Chapter 1.
Health Literacy and Health Outcomes
Asthma
According to one study, the lifetime economic costs for all people born in the year 2000
who develop a diagnosis of asthma will be $7.2 billion, including $3.2 billion in medical costs
and $4 billion in work/productivity loss (Corso & Fertig, 2009). Given the economic impact that
asthma can have on both the patient and the workplace, asthma was included as one of the
chronic conditions examined in this MTM study. Of the 90 participants, 13.33% reported being
diagnosed with asthma, and of this group, 16.67% had limited health literacy.
When the Asthma Control Test was administered to patients diagnosed with asthma,
75% had scores indicating that their asthma was not as controlled as it could be. This
percentage was higher than expected, perhaps indicating a need for patient education in the
management of their disease. Of those with sub-optimal asthma control, 22.22% of patients
had limited health literacy.
Although limited health literacy was not found to be associated with either asthma
groups, when the logistical regression model was formulated, asthma did become a predictor of
limited health literacy.

This finding is in keeping with other studies that have shown

associations between health literacy levels and asthma outcomes, including asthma control
(Gazmararian, Williams, Peel, & Baker, 2003; Mancuso & Rincon, 2006). It is also important to
note that ethnic differences in asthma prevalence, morbidity and mortality are highly
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correlated with poverty, urban air quality and lack of patient education (Asthma and Allergy
Foundation of America, 2011)
To help their patients with asthma better manage their condition, pharmacists are in a
position to help with asthma education. Patient education can include helping patients identify
those items that can trigger an asthmatic event, and reviewing patient education materials for
readability and the inclusion of culturally sensitive content. The latter is especially true for
pharmacists serving urban populations, as commonly used educational materials in these
settings have been found to be written at higher grade levels and often do not contain
ethnically -related information (Wilson, 1996).
Diabetes Mellitus
As stated earlier, given the complexity of managing diabetes mellitus, health outcomes
for adults with diabetes mellitus are better for those who can optimally incorporate selfmanagement of their diseases into their daily lives (Sigurdardottir, 2005). Diabetes care
requires informed individuals who can seek, obtain, and comprehend information to engage in
the management of their health (Morris, et al., 2006).
When entering the study, 12.22% reported having been diagnosed with pre-diabetes,
and 10.0% reported having type 1 or type 2 diabetes mellitus. As part of this MTM study,
fasting blood glucose tests were administered by pharmacists to all 90 participants. As a result
of these fasting blood glucose tests, an additional 20 patients (28.57% of the population) were
diagnosed with pre-diabetes, and one patient was newly diagnosed with type 2 diabetes. These
results show the value of fasting blood glucose tests as a part of an MTM program in helping in
the early detection of diabetes.

80
In addition, for those nine patients diagnosed with type 1 or type 2 diabetes mellitus,
blood glucose and cholesterol tests were performed to determine if blood glucose levels and
lipoproteins (LDL) were in optimal range. Of this group, 55.56% had results on both of these
tests outside the optimal range. This is an important finding, as patients with diabetes mellitus
should maintain proper blood glucose and LDL levels as a part of managing their chronic
condition. Herein, too, lies an opportunity for pharmacists to better serve patient needs and
improve health outcomes.
Cardiovascular Disease/Hypertension
Hypertension affects approximately 65 million people in the U.S. (Fields et al., 2004) and
is a risk factor for congestive heart failure, stroke and renal disease (Neal, MacMahon, &
Chapman, 2000). An important element in reducing the incidence of hypertension-related
cardiovascular disease is to increase the number of people who maintain adequate blood
pressure control (Bosworth, et al., 2005). In spite of effective drug therapies being available,
only 37% of hypertensive patients maintain proper blood pressure levels (Healthy people 2010:
Understanding and improving health, 2000).
In this study, 33 patients (36.66%) reported being diagnosed with hypertension. When
these 33 patients had their blood pressure measured by pharmacists, 81.82% of these patients
did not have adequate blood pressure control. This percentage (81.82%) is over two times
higher than the national average. Of those patients not reporting being previously diagnosed
with hypertension, blood pressure measurements indicated that three participants (3.33%)
suffered from pre-hypertension (> 120/90 mm Hg).
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Regarding the health literacy of the patients in these categories, 18.18% of those
reporting being diagnosed with hypertension had limited health literacy, and of the 27
hypertensive patients in the study whose blood pressure was less than optimal, the data
revealed that 22.22% had limited health literacy. All three of the participants not previously
diagnosed with hypertension had adequate health literacy. Although limited health literacy was
not found to be statistically significant in those diagnosed with hypertension or those found to
have pre-hypertension, in the logistic regression model, hypertension was found to be a
predictor of limited health literacy.
Pharmacists are highly accessible healthcare professionals and as such, pharmacists
have a unique opportunity to influence the health outcomes of patients with hypertension by
playing a more active role in assisting hypertensive patients in the management of their disease
(Santschi, Chiolero, Burnand, Colosimo, & Paradis, 2011). This would include monitoring the
blood pressure of their patients, as well as (as we will see below) helping them achieve target
cholesterol levels. This study underscores the importance of ensuring future pharmacists
receive specific instruction in how to take blood pressure readings, along with administering
and interpreting other laboratory tests. It also highlights the importance of the inclusion in
pharmacy education of information concerning the relationship of limited health literacy and
hypertension.
Dyslipidemia
Dyslipidemia is a condition marked by abnormal concentrations of lipoproteins (or
lipids) in the blood. Dyslipidemia is often associated with diabetes mellitus and cardiovascular
disease. For purposes of this study, dyslipidemia was determined by participants' self-report of
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being diagnosed with dyslipidemia. The level of a patient's dyslipidemia was measured by the
administration by pharmacists of a blood test measuring: triglycerides, total cholesterol (TC),
high density lipoprotein (HDL), and low density lipoprotein (LDL) cholesterol.
In this study, over half of the participants (52.22%) reported having been diagnosed
with, and taking medication for, dyslipidemia. Of these patients, 27.66% had higher than
normal total cholesterol levels and 34.0% had both sub-optimal HDL levels and higher than
normal triglycerides. 44.68% of this group had LDL levels indicating having moderate risk for
cardiovascular disease and 19.15% had LDL levels indicating high risk for cardiovascular disease.
These findings are in keeping with at least one other pharmacy-led study that indicated only a
minority of patients with cardiovascular disease factors achieve targeted goals for LDL (Pearson,
Laurora, Chu, & Kafonek, 2000).
When examining the prevalence of limited health literacy of these patients, only 8.51%
of those patients diagnosed with dyslipidemia had limited health literacy. However, for those
same patients in this group who had higher than normal total cholesterol levels, the prevalence
of limited health literacy increased to 15.38%. For those among this group with sub-optimal
HDL levels and higher than normal triglycerides, the number of those with limited health
literacy was 6.25%. Of those having LDL levels showing a moderate risk of cardiovascular
disease, 9.52% had limited health literacy levels, and interestingly, none of those who showed a
high risk of cardiovascular disease had limited health literacy.
When taken individually none of these groups showed a statistically significant
association with health literacy; however, when the logistical regression model was
constructed, dyslipidemia was shown to be a predictor of health literacy.
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Anxiety/Depression
Past studies examining the association of health literacy in patients with anxiety and
depression have had varying results. Of the 90 participants in this study, 27.8% reported having
being diagnosed with depression or anxiety and having been prescribed medication to treat
their condition. To help gain an understanding of how effective their medication was in
managing their condition, these patients completed the Zung Self-Rating Depression Scale. Of
the 25 participants having been diagnosed with depression or anxiety, 20% scored > 50 points
on the Zung Self-Rating Depression Scale, indicating the presence of depression. This result
suggests that, for most of the patients in the study diagnosed with anxiety or depression, their
medication regimen seems to have been effective.
Need for Patient Education and Identification of Sub-Optimal Drug Regimens
As mentioned in Chapter 1, the Accreditation Council for Pharmacy Education revised its
accreditation standards in 2006 to require that schools of pharmacy include training in the
patient-centered pharmaceutical care model. These revisions were the result of a paradigm
shift that has taken place in the profession as pharmacists seek to expand their role beyond the
person responsible for the distribution of medicine. Although this role remains an important
part of the activities of a pharmacist (as seen in this MTM study), increasingly, pharmacists are
taking a more active role in the clinical care of their patients.
Today, pharmaceutical care includes working in concert with the patient and the
patient's other healthcare providers (e.g. physicians, nurses, physician assistants) to promote
better health, prevent disease, and in general, help improve health outcomes. This includes
assessing the need for, and the provision of, appropriate patient education. It also involves
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pharmacists assessing, monitoring, initiating, and modifying medications to help assure that
drug therapy regimens are safe and effective. These activities are most aptly carried out as a
part of an MTM program, specifically through pharmacist-lead patient interviews.
Need for Patient Education
As a part of this study, patient interviews were conducted to help identify specific areas
in which patients needed education, including issues involving their drug regimens and lifestyle.
A full 100% of the participants needed some form of patient education. More particularly,
94.44% needed education on the proper use of their medication and 56.66% could benefit from
education on self-care (i.e. non-medication related improvements, like avoiding problematic
foods).
Adherence is often described as the extent to which a person's behavior (e.g. taking
medications) coincides with medical or health advice (Meichenbaum & Turk, 1987). Patient
interviews revealed that 64.44% of all patients required assistance adhering to their medication
regimen. As medication adherence is often problematic for patients with chronic conditions, a
separate test (e.g. Modified Morisky Scale) was administered to those in the study. On this selfreported test, only 21.11% of the participants had scores indicating less than optimal drug
adherence. The reason for these conflicting results is unknown, although it seems reasonable
to consider that patient interviews may more accurately reflect patients' adherence rates.
It was also found that 16.67% of the population could benefit from education on
improving the use of their health monitoring devices, while 78.89% of the participants needed
education on disease state management (e.g. seeking regular laboratory tests, monitoring
blood pressure). The last educational category was the need for information on lifestyle
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changes, which included suggestions for additional physical exercise and/or weight loss. The
data showed that 88.89% of the participants needed additional help in this area. Importantly,
many of these recommended changes could be implemented by patients without physician
approval.
The above findings were in keeping with Body Mass Index (BMI) calculations, which
revealed that 74.45% of the total population was either overweight or obese. Obesity remains
an important concern of healthcare professionals as it can lead to chronic diseases such as
diabetes mellitus and hypertension.
However, neither the general category of the need for patient education nor any of its
sub-groups had a statically significant association with health literacy. BMI calculations also
were not associated with health literacy. None of these areas were found to be predictors of
health literacy in the logistical regression model.
Identification of Sub-Optimal Drug Regimens
Patient interviews were also conducted as a part of this MTM study to help pharmacists
identify specific problems concerning patients' medication regimens. The 1995 landmark study
conducted by Johnson and Bootman projected that healthcare costs associated with drug
therapy problems was projected to be $76.6 billion (Johnson & Bootman, 1995). In 2001 when
the study was updated, projected costs associated with drug therapy problems had increased
to $177.6 billion (Ernst & Grizzle, 2001). In this regard, MTM programs have proven to be very
helpful, as pharmacists can play a valuable role in identifying drug problems and increasing
medication safety, thereby substantially reducing healthcare costs.
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In this study, pharmacist-led interviews revealed that 83.33% of patients had suboptimal drug regimens. For purposes of analysis, the sub-optimal drug regimen category was
broken down into 12 different types of drug-related issues. The prevalence of these 12 issues
are described below.
Of these 75 patients who had sub-optimal drug regimens, 4.0% were taking unnecessary
medications, and 2.67% were prescribed ineffective medications. 6.67% had drug regimens of
excess dose or duration, while 17.33% of the patients had drug regimens involving insufficient
dose or duration. 2.67% were found taking excessive amounts of medications, while 12.0%
were underutilizing their medications. 5.33% of the patients reported adverse events relating
to their drug regimens and 2.67% required additional drug information. The study also found
that 6.67% of these patients needed additional or follow-up laboratory monitoring.
Although these issues involved smaller segments of the population, the identification of
these problems provided an opportunity to significantly reduce the healthcare costs associated
with medication-related complications at this self-insured university.
There were a few other important findings within this group. These include that 25.33%
of the patients exhibited ineffective administration of their medication and 28.0% were found
to be in need of additional medication therapy to help better manage their chronic condition(s).
Finally, 46.67% were prescribed medication(s) for which there was a more cost effective
(cheaper) medication option. As a part of this MTM program, patients had the option of having
the pharmacist share this information with their physician, providing an opportunity for
significant cost savings to both the patient and the institution.
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With regard to health literacy, of all of these sub-groups within this sub-optimal
medication regimen section, no statistical significance was found with health literacy, nor were
the sub-groups found to be a predictor of health literacy in the logistical regression model.
Limitations and Strengths of Study
Several limitations of this study should be considered. First, these data reflect the
results of one MTM study, conducted as a part of health wellness program at a small midwestern university. It is possible that different findings could be found from a broader selection
of study sites, especially those with more diverse patient populations. The second limitation
was the number of the participants. Having only 90 patients taking part in the study limited
definitive conclusions. A third limitation was the study's design. As it was a cross-sectional
study, it provided information about the associations of limited health literacy and certain
chronic diseases, but did not address causality. Therefore, such inferences must be made with
caution.
Despite these limitations, this study has significance. Numerous medical studies have
examined health literacy as it relates to health outcomes for patients with chronic conditions.
Additionally, many pharmacist-led MTM studies have examined the effectiveness of MTM
programs aimed at improving the health outcomes of these same patients. However, what
makes this study unique is the inclusion of health literacy assessment as a part of a MTM study.
Despite being delineated as a part of the American Pharmacists Association and National
Association of Drug Stores Foundation's MTM model framework, health literacy remains a
relatively under-explored area in pharmacist-led MTM studies. This study contributes to our
understanding in this important area.
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This study also suggests that to be fully effective in their expanding roles, pharmacists
need to be aware of the health literacy levels of their patients, especially those pharmacists
more actively assisting in health care of patients with chronic conditions. Finally, as future
healthcare professionals, pharmacy students should receive instruction on the relationships of
health literacy and health outcomes, including the importance of the inclusion of health literacy
assessment as part of a comprehensive medication therapy management program.
Implications for Future Research
Based on this study, several recommendations for future research can be made. This
MTM study involved only one location which had a homogeneous population. Other MTM
studies should be conducted which assess the health literacy of participants, especially those
involving more diverse populations. If possible, data from this MTM study site should be
aggregated with other MTM studies. Further exploration of the differences in limited health
literacy between women and men in these programs would also be beneficial.
As there was a six-month follow-up visit for patients in this study, assessments should
be made to determine if the interventions of this pharmacist-led program resulted in
improvements in the health outcomes of the participants. Financial savings associated with the
recommended changes in drug therapies should also be examined, as it would be difficult to
imagine that there would be none following these pharmacist-led interventions.
Calculating both the costs associated in implementing this MTM program and the fair
market value of the laboratory tests conducted by the pharmacists would also be useful. These
items would help demonstrate the cost effectiveness and value added for MTM programs,
especially for self-insured entities.

These analyses could then be shared with doctor of
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pharmacy students, arming the students with the necessary data to assist them in effectuating
changes in the delivery of health care, especially for patients with chronic diseases.
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The role of pharmacists in the U.S. continues to evolve. Pharmacists are now being
trained to be drug information specialists and medication counselors.

More than ever,

pharmacists are helping patients with chronic conditions manage their diseases through the use
of medication therapy management programs. As a part of these programs, it is important that
pharmacists are aware of what effect their patients' health literacy level may have on health
outcomes.
The purpose of this study was to examine the extent to which health literacy was
associated with different demographic factors and the extent to which health literacy was
associated with clinical outcomes for patients with asthma, diabetes mellitus, cardiovascular
disease/hypertension, and depression/anxiety in a well-defined, self-insured university
population.
To answer the research question, data from the pharmacist-led program "Medication
Therapy Management and Health Literacy Assessment through Health Horizons: Manage My

114
Medications" was analyzed. Data were collected on demographic, psychosocial, and physical
functioning using standard assessment instruments and patient interviews.

Additionally,

certain clinical tests were performed to assess and gain an understanding of the control of
patients' disease state(s). Data was collected at two points – upon entering the program and at
six months. This study only examined baseline data.
For this study, patients were categorized by having either limited health literacy or
adequate health literacy. Of the 90 participants enrolled, 11.11% had limited health literacy;
88.89% demonstrated adequate health literacy. The results revealed that at the p<0.05 level,
men were significantly more likely to have limited health literacy than women (p=0.049). Age
was also found to be associated with health literacy. When divided in groups <50 years of age
and > 50, there was a significant association between health literacy and age (p=0.02). When
considering years of formal education, patients with lower levels of educational had greater
lower health literacy. Among different educational levels, there was a significant association
between health literacy and education (p=0.024).
When considered individually, health literacy was not found to be associated with any
clinical outcomes of asthma, diabetes, mellitus, cardiovascular disease/hypertension, and
depression/anxiety; higher body mass index (BMI), higher blood pressure, higher fasting blood
glucose levels, and dyslipidemia; lower medication adherence; the need for patient education;
and sub-optimal medication regimens.
However, when a logistic regression model was constructed, self-reported diagnoses of
asthma, hypertension and dyslipidemia were found associated with heath literacy along with
gender, age, and education. The final model was highly significant (p < 0.001).
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The results of this study demonstrate the need for more research on the role of health
literacy assessment in medication therapy management programs. Likewise, information on
the relationship between health literacy, patient demographics, and health outcomes of
patients with chronic conditions should be included in pharmacy education curriculum.
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